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Stimulated Transmission Emission Depletion (STED) microscopy was used to 
characterize the nanoscopic morphology of wild-type peroxisomes under normal 
and proliferative conditions in mammalian cells and in yeast Saccharomyces 
cerevisiae (in this text referred to as yeast). In yeast, the new peroxisomal protein 
Pex35 was characterized by analyzing the subdiffraction size and morphology of 
peroxisomes in wildtype, and pex35 mutant strains. Only STED microscopy could 
reveal the Pex35 overexpression phenotype, which resembled hyper-vesiculation 
of clumped peroxisomes within a subdiffraction volume. This remarkable 
subdiffraction phenotype supports the hypothesis that PEX35 regulates 
peroxisome abundance by an Arf1 dependent vesiculation mechanism. 
In mammalian HeLa cells, the colocalization of the translocon complex 
and peroxisomal fission factors on peroxisome membranes were analyzed at the 
nanoscale. RING (PEX2-PEX10-PEX12) and docking (PEX13-PEX14) 
subcomplexes of the translocon machinery were found to localize on distinct 
membrane substructures. We also used STED microscopy, and developed an 
automated imaging analysis pipeline in CellProfiler (www.cellprofiler.org)  to 
analyze the sub-diffraction morphology of the cellular peroxisomal ghost 
phenotype in Peroxisome biogenesis disorder patient cells (Zellweger Syndrome 
Spectrum phenotype). The size of the peroxisomal ghosts was found to correlate 
with import deficiency, integral peroxisomal membrane (PMP70) protein 
abundance, and the clinical severity of the patients. This is the first time that the 
membrane ghost phenotype associated with Zellweger Syndrome Spectrum 
disorder could be shown to correlate with the clinical severity and import 
deficiency in patients’ fibroblasts. Overall, this work forwards the characterization 






1.1. Peroxisome biogenesis 
Peroxisomes are single membrane bound eukaryotic organelles that carry 
important metabolic and signaling functions. They were first described using 
electron microscopy (EM) in liver tissues, and in 1966, Christian De Duve 
described a microsomal liver fraction that was rich in catalase, a hydrogen 
peroxide detoxifying enzyme, and hence they were termed “peroxisomes” [1]. 
Peroxisomes are evolutionary conserved in many species, except for some 
eukaryotes which do not have peroxisomes, others may contain specialized 
classes of peroxisomes that have different designations [2]. For example, in 
Neurospora crassa, fungi they are known as “woronin bodies” and Trypanosoma 
brucei parasites they are named “glycosomes” [3, 4]. In humans, peroxisomes 
are ubiquitous in all cells, except for mature red blood cells [2]. The ultrastructure 
of peroxisomes has been extensively studied using EM methods: Peroxisomes 
have normally spherical structures, but they can also have tubular, elongated 
structures that show segmentation [5]. In general, their size can vary between 50 
nm and 1 µm [2]; however, in mammalian cells, the majority of peroxisomes 
shows a small profile (50 – 200 nm in diameter) [5], which lies at the diffraction 
limit of light microscopy [6].  
Peroxisomes are semiautonomous organelles, they derive their 
membranes from endoplasmic reticulum, but they can also form by division from 
pre-existing peroxisomes [7]. Peroxisome lumen (matrix) is filled with matrix 
proteins most of which are metabolic enzymes [2]. Matrix proteins are imported 
into peroxisomes using peroxisomal targeting sequences: PTS1 (C-terminus) or 
PTS2 (N-terminus) via PEX5 and PEX7 soluble matrix receptors, respectively [8]. 
Matrix proteins have been shown to translocate into peroxisomes in their 
oligomeric folded form and it is thought that the translocation mechanism does 
not require energy (ATP), but recycling of matrix receptors back to the cytosol is 




peroxisome matrix and membrane proteins as perfectly colocalized structures 
and it is not possible to demarcate the peroxisomal compartment with the 
peroxisomal membrane (Fig. 1.1).     
 
Figure 1.1 Confocal microscopy of peroxisomes.  
Single peroxisome in Human Skin fibroblast (HSF) cell stained with PMP70 (left) 
and Catalase (middle) primary antibodies. Labeled with KK114 and Atto590 
conjugated secondary antibodies, respectively. Merged overlay (right). Images 
were smoothed with 3x3 average filter. Scale bar 500nm.  
 
The process of peroxisome biogenesis (de novo synthesis) can be divided 
into two events: 1) early membrane biogenesis, and 2) translocon maturation and 
matrix protein import, both of which require PEX gene-encoded peroxins [11]. 
Most peroxins are integral peroxisomal membrane proteins (PMPs), while some 
are soluble proteins that show bimodal distribution between the cytosol and 
peroxisomal membranes, e.g. PEX5, PEX1 and PEX6 (AAA proteins) [12]. They 
are named and numbered by order of identification (e.g. PEX1, PEX2, etc.) [13]. 
In the yeast Saccharomyces cerevisiae, which I will refer to as yeast throughout 
the text, there are 34 peroxins, whereas in humans there are only 14 known 
peroxins [2]. A current model of peroxisomal membrane biogenesis implies that 
type-III membrane peroxins, also known as early membrane peroxins (PEX3, 
PEX16 in humans, and PEX27 in yeast), which target to the ER, primarily with 
help of the ER secretory apparatus [14, 15]. Early membrane peroxins together 
with PEX19, a soluble cytosolic chaperone, are then required for the direct 




[16]. Integral PMPs contain a membrane peroxisomal targeting sequence 
(mPTS) [17]. Type-I integral PMPs are the RING subcomplex peroxins (PEX2, 
PEX10, and PEX12) and the docking subcomplex components (PEX13 and 
PEX14) of the peroxisomal translocon, in addition to membrane transporters, e.g. 
PMP70 and ALDP [18]. Type-I integral PMPs are translated on free cytosolic 
polysomes, despite the fact that some of them have been shown to carry ER 
targeting signals, e.g. PMP70 [19].  
In yeast, it has been shown that RING and docking components localize to 
distinct ER derived pre-peroxisomal vesicles, which later mature into import 
competent peroxisomes via heterotypic fusion aided by PEX1 and PEX6 AAA 
membrane associated peroxins  (Fig. 1.2) [20].  
 
 
Figure 1.2 Peroxisome biogenesis model. 
Two pre-peroxisomal vesicles (PPVs) arise from the ER harboring RING and 
docking subunits, which fuse by help of PEX1 and PEX6. The resulting mature 
translocon translocates matrix proteins into the peroxisomal matrix. (Adapted 





When a mature peroxisomal translocon is formed, cargo matrix receptors 
dock and translocation of cargo to the inner peroxisomal membrane matrix space 
occurs [21, 22]. However, in mammals how the translocon is formed is not clear 
and the colocalization and distribution of RING and docking peroxins remains to 
be elucidated.    
1.2. Peroxisome proliferation and fission 
In addition to de novo synthesis, peroxisomes control their abundance by 
proliferation and division using PEX11 proteins [23], and fission factors that are 
shared with mitochondria [23]. The transcriptional regulation of peroxisome 
proliferation is carried out by the Peroxisome Proliferator-Activating Receptors 
(PPARs), and Oleate activated factors (Oafs) in humans and yeast, respectively 
[24, 25]. There are pharmacological substances, hypolipidemic drugs, that can 
stimulate peroxisome proliferation and hence increase their abundance [26, 27]. 
Further, yeast grown on glucose-rich media, contains fewer (2-3 per cell) and 
smaller peroxisomes (100 – 200 nm), [12]. Since beta-oxidation of very long 
chain fatty acids (VLCFAs) is a key metabolic pathway that only takes place in 
peroxisomes, it was shown that by adding VLCFAs, such as Oleic acid or 
Palmitic acid to yeast cultures, peroxisome proliferation and division is induced 
[28]. Such chemicals have been used to assess peroxisome function and aided 
the discovery of new peroxisomal proteins [29].  
Induced peroxisomes require PEX11 protein for elongation and fission 
[30]. In humans, there are three of PEX11 isoforms (alpha, beta, and gamma), 
with PEX11beta being the most important one responsible for majority of 
peroxisomal proliferation events in the cell [31]. Overexpression of PEX11beta 
leads to elongated peroxisome (hypertubulation) [31, 32]. The ultrastructure of 
these hypertubulated structures indicated a steady subdiffraction diameter of 80 
– 100 nm [31]. PEX11 has been shown to accumulate at constriction sites with 




contribute to fission by a membrane deformation mechanism [33]. DLP1 (or 
Dnm1 in yeast), a small GTPase proteins that forms helical rings around 
mitochondrial and ER membranes to induce constriction and fission, was the first 
peroxisomal fission factor discovered [34]. PEX11 overexpression recruits DLP1 
to peroxisomes, and other fission proteins were shown to be important for the 
recruitment of DLP1 to peroxisome membranes [23, 35]. For example, the tail-
anchored Mitochondrial Fission Factor (MFF) and Fission factor 1 (FIS1) proteins 
[36]. Using indirect immunofluorescence and conventional fluorescence light 
microscopy DLP1 was found to localize on peroxisomal membrane termini in 
PEX11 overexpression [34]; however, the function of DLP1 at termini is 
unknown. Unlike for mitochondrial DLP1 [37], there are no quantitative data 
about peroxisomal DLP1. 
1.3. Peroxisome Biogenesis Disorders (PBDs) 
Mutations affecting PEX genes are the cause of rare lethal metabolic disorders, 
termed as Peroxisome Biogenesis Disorders (PBD) [38]. PBDs are neurological 
pediatric disorders that lead to early lethality in the majority of the cases. PBDs 
can be divided into two groups: (1) Zellweger Spectrum Syndrome (ZSS) 
affecting up to 16 PEX genes (i.e. 16 complementation groups), and (2) 
Rhizomelic Chondrodysplasia Punctata Type-1 (RCDP-1) where only PEX7 is 
involved [39]. RCDP-1 mutations lead to import defects of PTS2 matrix proteins, 
while ZSS mutations cause PTS1 and PTS2 import defects, with mutations in 
PEX1 being responsible for ~ 80% of the cases [40, 41]. The ZSS is a continuum 
of clinical symptoms with the most severe and mildest cases, the Zellweger 
syndrome (ZS) and Heimler Syndrome (HS), respectively [39, 42]. ZS patients 
show a genotype-phenotype correlation, which means that the severity of the 
phenotype correlates with the severity of mutation on the function of the encoded 
protein [41]. Low abundant membrane remnants (ghosts) structures devoid from 
matrix content, and accumulation of VLCFA are cellular hallmarks of ZS [41]. 
Ghosts ultrastructure in EM appear as enlarged membrane structures with 




protein content [43]. There are no quantitative data and phenotype-genotype 
correlations with respect to ghost structures in ZS. In human cells, it is very 
difficult to find them by EM; however, early EM data have revealed ghost 
structures that can reach two to four times the size of normal peroxisome [44]. 
Immunofluorescence imaging provided a good alternative method to visualize 
human ghost structures and patterns [44]. Using manual scoring and wide-field 
microscopy, ZS patients’ skin fibroblast cells with higher frequency of large 
ghosts have been found, while other patients’ cells revealed normal size 
peroxisome structures or a mixed pattern of both large and normal size ghost 
particles [44]. After the identification of affected genes in humans and yeast, data 
suggest that enlarged abnormal ghosts’ particles indicate mutations in AAA 
peroxins (PEX1 and PEX6) and docking factors (PEX13 and PEX14), whereas 
mutations in RING peroxins are accompanied by virtually normal ghost 
appearance compared to control cells [44, 45]. Mutations affecting early 
membrane peroxins and PEX19, were shown to be devoid of membrane 
remnants leaving integral PMPs unstable [46]. Despite the early efforts to classify 
ghosts in ZS patients’ cells, a proper quantitative classification does not exist, 
and in humans PEX10 and PEX13 ghosts’ pattern remains to be elucidated. 
Further, differences in protein levels of the integral PMP, PMP70, have been 
observed in biopsies of different ZS patients [47]; however, whether differences 
in protein abundance play a role in the ghost size heterogeneity in these patients 
remains unknown. 
1.4. YGR168C regulates peroxisome abundance in yeast  
Yeast is one of the well characterized and most frequently used models to study 
organelles and their biogenesis, including peroxisome [48]. Most PEX genes in 
humans are evolutionary conserved in yeast and many orthologues were first 
identified in yeast [2]. Easy genetics, faster doubling time, and ease of handling 
favored yeast systems over mammalian systems in the discovery of new 
peroxisomal proteins [49]. Yeast cells can be maintained in their haploid or 




the haploid state, while the diploid state can be used for crosses to produce 
haploid strains, for example, with multiple knockouts [50]. As mentioned earlier, 
there are 34 PEX genes in yeasts; PEX34 is the last identified peroxin, which 
functions together with PEX11 to control peroxisome numbers [51]. PEX11 family 
proteins in yeast consist of Pex11, Pex25 and Pex27, which are involved in 
peroxisome fission and proliferation [2]. Other proteins, which target to different 
organelles and locations in the cell e.g. DLP-like Vps1, actin, myosin receptor 
(Myo2p) and ADP-ribosylation factors (Arfs), have been also shown to control 
peroxisome abundance and inheritance [52, 53]. Despite the large number of 
factors discovered that control peroxisome numbers, the mechanism by which 
peroxisome abundance is controlled remains elusive. This maybe partially due to 
unknown key players in the mechanism controlling peroxisome abundance that 
remain to be elucidated.   
Initially, yeast screens were dependent on growth on oleic acid plates to 
identify PEX genes due to their ability to utilize oleic acid (C18:1), which can only 
be metabolized by peroxisomes [54, 55]. Yeast strains with defects in 
peroxisome abundance or beta fatty acid oxidation function show reduced halos 
around colonies, and reduced growth in oleic acid liquid cultures as well as 
reduction in oleic acid consumption [56, 57].  
Microscopic screening methods have recently gained increased interest, 
because they offer additional readouts compared to metabolic growth effects [58, 
59]. Improved genetic integration cassettes, deletion and overexpression libraries 
collections, and synthetic genetic array (SGA) genetic interaction analysis in 
combination with HTS assays provided new results [59, 60].  
Our lab in collaboration with M. Schuldiner’s Lab has initiated a genome 
wide-screen to hunt for more peroxisomal proteins that control peroxisome 
abundance or size. To achieve that, our lab first constructed a query strain with 
fluorescently tagged early membrane peroxin (PEX3-mcherry) and ER marker 
protein (Spf1-GFP), then they performed automated SGA crossings of this query 




essential genes, as described earlier [61]. Using HTS microscopy and high-
content screening they analyzed peroxisome number per cell, and they found 
enriched PEX genes and other peroxisome associated proteins known to affect 
peroxisome number on top of their list. Among the top list of proteins, a 
previously uncharacterized gene, YGR168c, appeared with severe reduction in 
peroxisome number. Colocalization widefield microscopy analysis revealed 
peroxisomal colocalization of its encoded protein. Interestingly, deletion and 
overexpression of Ygr168c showed reduction in peroxisome abundance under 
glucose as well as oleic acid conditions (Yofe et al, unpublished).  
Multiple screens were then carried out to characterize the function of 
Ygr168c. First, a synthetic lethality screen has been done to uncover important 
pathways when ygr168c is mutated, in which a ygr168c deletion strain was 
crossed with a deletion library comprised of ~ 6000 genes, previously used in the 
microscopy screen (Yofe et al, unpublished). The synthetic lethality screen 
demonstrated a strong link between YGR168C with genes of redox homeostasis 
and amino acid metabolism e.g. arginine biosynthesis. Another protein-protein 
interaction screen that used fragment complementation of two parts of 
dihydrofolate reductase (DHFR) was carried out to attempt further 
characterization of YGR168C function with respect to number and size of 
peroxisomes. The interaction split assay enabled the tracking of YGR168C 
interaction with all yeast proteins (Yofe et al, unpublished). The results of DHFR 
interaction screen indicated several PEX and non-PEX interaction partners to 
YGR168C, which play roles in peroxisome biogenesis and division. Most 
importantly, the PEX11 family proteins: PEX11 and PEX25, and the ARF 
proteins: Arf1 and Arf2 (Yofe et al, unpublished). Further, YGR168c 
overexpression was shown to lead to Arf1 dissipation from the Golgi to the 
cytosol, which is reminiscent of increased GTPase Activating Protein (GAP) 
activity or decrease in Guanine nucleotide Exchange Factor (GEF) activity (Yofe 
et al, unpublished). Deletion of Arf1 in ∆ygr168c lead to worsening of the 




rescued peroxisome size and numbers (Yofe et al, unpublished). Why 
peroxisomes appear bigger and less in both of ygr168c deletion and 
overexpression in confocal microscopy remains puzzling and require further 
investigation.  
     
1.5. Super-resolution STED microscopy  
Diffraction-limited light microscopy cannot resolve structures at a distance below 
200 nm, because light propagates as a wave and thus constrained by a physical 
phenomenon known as “diffraction” [62]. The diffraction limit is about ½ the 
wavelength of excitation light (visible light spectrum: 400 nm – 800 nm), as 
described in the 19th century by Ernst Abbe’s equation [63]. In the 21th century, 
the diffraction barrier was broken in experiments conducted by Stefan Hell, 
William Moerner, and Eric Betzig [64]. Previous ideas to improve resolution were 
focused on improving optical elements of microscopy and imaging near to 
specimen (near-field microscopy), which was impractical for many cell biology 
applications compared to far-field microscopy [63]. The basic principle of Stefan 
Hell, Eric Betzig, and William Moerner ideas and experiments was to modulate 
the transition state of fluorescence molecules rather than improving optics, and 
this laid the foundation of far-field super-resolution microscopy [65]. According to 
their work, the ON/OFF (excited “fluorescence” and de-excited “dark”) states of 
fluorophores can be modulated temporally or spatially by stochastic emission and 
stimulated emission, respectively [66, 67]. Photoactivatable Light Microscopy 
(PALM) and Stochastic reconstruction microscopy (STORM) use temporal 
properties to obtain super-resolution images; they depend on the photo activation 
of photo switchable fluorophores or the stochastic activation of fluorescent 
molecules by using short excitation pulses, respectively, and images are 
collected by camera grid over many cycles of frames [68]. In each frame, only a 
subpopulation of single fluorophore emitters is turned ON, and at the end of 
repetitive light activation, a super-resolution image is reconstructed 




position on the camera detector [69]. In the case of Stimulated Transmission 
Emission Depletion (STED) microscopy, two co-aligned laser beams are used; 
one excitation beam and another azimuthally polarized (doughnut -shaped) 
depletion (STED) beam with a zero minima intensity (ISTED ≈ 0 mW)  at the 
doughnut  center [70]. When the two beams illuminate a fluorescent sample, only 
the molecules from the center of the doughnut  are excited, whereas the other 
molecules hit by the STED beam are de-excited instantaneously to the reversible 
non-fluorescent (dark) states [66, 71]. Using the same principle of diffraction, the 
doughnut ’s center can be adjusted, to few nanometers, by increasing the power 
of the depletion beam (Fig1.3) [71, 72].  
 
 
Figure 1.3 STED microscopy, principle.  
Cartoon illustrating the principle of Stimulated Transmission Emission Depletion 
(STED) microscopy and resolution enhancement provided by STED laser. The 
green circle indicates the excitation laser focus and the red doughnut circle 
indicates the STED laser.  
   
In practice, STED microscopes reach a resolution of 20 - 30 nm because 
of depletion efficiency at lower STED power and the irreversible chemical 
destruction of organic fluorescent molecules (photobleaching) at high laser 
powers [73]. Gated-STED, pulsed-STED lasers, or a combination of the two 
techniques enabled efficient STED imaging at high resolution within acceptable 
laser powers for both live and fixed biological samples [74]. Using very stable 




high powers and achieve a resolution down to the dimensions of atoms (0.1 nm) 
[75, 76]; however, stable organic fluorophores remain the best choice when it 
comes to life sciences applications. Two excitation laser (two color) STED 
microscopy with one depletion beam has been successfully shown to obtain two 
color super-resolution images using two spectrally distinguishable dyes, with 
resolution down to 20 nm in X-axis and Y-axis in both recorded channels [77]. 
This offered great advantage to conventional confocal colocalization microscopy, 
because only excited fluorophores from the center of the STED doughnut  emit 
fluorescence in both wavelengths, which means that there will be no offset error 
that normally occurs due to the need to align the excitation lasers [77].  
Super-resolution microscopy offers a useful tool in biology, because most 
of biological structures revealed a size and ultrastructure below diffraction limit of 
light [68]. The first super-resolution images in a cell showed vacuolar membrane 
details in yeast at unprecedented details [78]. Many eukaryotic organelles have 
been revealed at nanometer resolution using super-resolution microscopy [79–
82]. Antibody immunofluorescence has been the most used technique, to label 
biological samples for super-resolution imaging, because it offers high labeling 
densities and photostability of the conjugated organic fluorophore dyes [83]. 
Although antibody labeling remains the most commonly used labeling strategy, 
they impose disadvantages that become evident at subdiffraction resolution, 
such as big label size and the steric hindrance [84]. Therefore, smaller affinity 
labels such as single-domain antibodies (nanobodies) or small-nucleic-acid 
ligands (aptamers), were developed and effectively used to overcome such 
complications that may associate conventional antibodies [85–88].  
  
1.6. Automated Imaging analysis for super-resolution 
microscopy 
Image analysis of images obtained from fluorescence light microscopy can be a 




results. Therefore, automated analysis pipelines offer an alternative to approach 
this problem [89]. Automated imaging analysis tools for fluorescence imaging 
have been developed, because of their importance for high-content-screening 
(HCS) and HTS cellular assays [90]. However, automated freeware analysis 
tools for super-resolution microscopy are not widely available and may still 
require further development to bring it to full automation [91–93]. When 
structures are revealed by super-resolution microscopy, it is often the case that 
structures reveal a subdiffraction pattern or clusters of biomolecular complexes 
and proteins. For instance, a nuclear pore immunostained with an outer ring 
marker, the scaffold protein gp210, revealed each nuclear composed of an 
average of ~ 8 gp210 subunits when imaged using STORM or STED microscopy 
[91]. So far, segmentation and analysis of individual nuclear pores for 
quantitative purposes, was accurately achieved by active cropping of individual 
pores or template matching algorithms, which is a very time consuming and 
requires Matlab (www.mathworks.com) programming skills, respectively [91]. 
Therefore, developing a method in which computer algorithms can automatically 
segment individual nuclear pores, at the same time exempting the user from prior 
knowledge or cost of any programming language will be substantially beneficial. 
Recently, an automated algorithm has been described that uses adaptive local 
density estimation kernels, in order to merge or separate groups of subdiffraction 
structures based on local density information [94]. However, such an algorithm is 
not yet available in readily available user-friendly platforms, and has only been 
tested on images from biological structures with continuous density profiles, such 
as mitochondria and tubulin. Developing another method that can be immediately 
implemented, and is able to efficiently segment structures with irregular 
fluorescent patterns and densities in images obtained by super-resolution 
microscopy, will be of great advantage.    
 Super-resolution microscopy techniques provide a much narrower 
Gaussian point spread function (PSF) of the focused scanning area, enabling us 




Smoothing functions algorithms are generally applied to images and to single-
molecule localization (image coordinate) data, in order to enhance 
structure/cluster segmentation [95]. Applying a Gaussian filter could also enlarge 
PSF of super-resolution images and drive resolution backward toward the 
diffraction limit of light in a controlled fashion by mathematical means e.g., 
increasing width of Gaussian (Fig 1.4). 
 
Figure 1.4 Fluorescent gold beads STED microscopy resolution.  
 (A) Raw STED image of 80 nm fluorescent gold beads (right) and Confocal 
overview (right) (B) Gaussian smooth of STED image image with sigma = 20 nm 
(left) and Gaussian smooth with sigma = 200 nm (right). 
 
An intuitive way to segment SR images (subdiffraction patterns) into 
meaningful objects would be through Gaussian smoothing to merge proximate 
signals within the artifact radius of the Gaussian. Once this grouping is achieved, 
fused neighboring objects remain to be segmented. Merged super-resolved 
subdiffraction structures might show intensity variation throughout the whole 
object. For that, it is logical to use algorithms that use shape information to 
segment clumped objects, avoiding by that over-segmentation problems [96]. 
Once objects in an image are perceived as biologically significant objects by 




remain possible to segment the actual SR image to find out single molecule 
clusters or subdiffraction pattern information within objects. Associating objects 
found in the SR image and its Gaussian blur, would then allow us to find out 
meaningful data about the biological structures in question. Free imaging  
software tools like CellProfiler (www.cellprofiler.org), possess all previously 
described algorithms and analysis paradigms [97], which should make it possible 
to implement Gaussian blur filters and combine image segmentation procedures 
to extract meaningful data from SR images in a fully automated way. 
 In this thesis, an automated imaging analysis method has been 
developed, based on Gaussian [98], which will be later used to analyze 
peroxisome structures (ghosts) in ZS patients.          
 
1.7. Aim of this study  
The aim of this work: 1) Characterize a novel peroxisomal yeast protein, mainly 
by using STED super-resolution microscopy, in addition to intracellular HPLC-
amino acid metabolomics, and biochemical techniques. 2) Study the 
subdiffraction morphology of peroxisomes in humans as well as the peroxisomal 
protein arrangements in wild-type and ZSS patient fibroblasts by STED 
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2. Materials and methods 
2.1. Materials List 
Chemicals list (A-Z) 
A 
Acetone ≥99, 7 %, Ph. Eur (Art Nr. CP40.2, ROTH) 
Agar-Agar KobeI (Art Nr. 5210.2, ROTH) 
Agarose Molecular Biology grade (Art Nr. 4105, Biochemica) 
Albumin Fraction V ≥98 %, powdered for molecular biology (Art Nr. 8076.2, 
ROTH) 
Amino acids (all from Sigma and ROTH) 
Ammonium Sulfate ≥ 99%, for molecular biology (Art Nr. A4418-1KG, Sigma) 
B 
BC Assay Reagent A (UP95424A, Uptima) 
BC Assay Reagent B (UP95425, Uptima) 
BigDye Terminator v.1.1 v.3.1 5x sequencing buffer (Aplied Biosystems) 
Bromophenol Blue (Merck) 
C 
Complete Easypack cocktail protease inhibitor (Art Nr. 04693116001, Roche) 
Concanavalin A (ConA) from Canavalia ensiformis (Jack bean) Type IV, 
lyophilized powder (Art Nr. C2010-25MG, Sigma) 
D 
D (+) Glucose nonhydrous (Art Nr. X997.2, ROTH) 
Dithiothreitol (DTT) (Art Nr. 20710.04, SERVA)  
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Dulbecco’s MEM (DMEM) – Low (1g/L D-Glucose) (Art Nr. F0415, Biochrom) 
E 
EDTA solution pH 8.0 (0.5 M) for molecular biology (Art Nr. A4892.0500, 
AppliChem) 
Ethanol absolute for analysis EMSURE® ACS, ISO, Reag. Ph. Eur (Art Nr. 
1.00983.2500, MERCK MILLIPORE) 
F 
Fetal Bovine Serum (FBS) Superior standardized (Art Nr. 90615, Merck) 
G 
Glycerol 99% (Art Nr. G901-2, Sigma) 
Glycine PUFFERAN® ≥99 %, p.a. (Art. 3908.2, ROTH)  
L 
LB-Agar (Art Nr. X969.1, ROTH) 
Lithium Acetate dihydride (L4158-250G, Sigma) 
M 
Methanol, 'BAKER ANALYZED’ (Art Nr. 8045.2500, AVANTOR)  
Milk Buffer, Blotting grade (Art Nr. T145.3, ROTH) 
N 
Nonidet™ P-40 (NP-40) (Art Nr. 74385-1L, Sigma) 
O 
Oleic acid ≥99% (GC), stored in the dark at -20°C (Art Nr. O1008-5G, Sigma) 
P 
Paraformaldehyde 37% (Art Nr. 1.04003.1000, Merck) 
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PBS Dulbecco w/o Ca2+ w/o Mg2+ low endotoxin (Biochrom) 
Penicillin-Streptomycin antibiotics (Art Nr. A2213, Merck) 
Peptone ex casein tryptic digest, for microbiology (Art Nr. 8986.2, ROTH) 
Phenylmethanesulfonyl Fluoride (PMSF) (Art Nr.  A0999.0029, AppliChem) 
Polyethylene Glycol (PEG) 4000 (Art Nr. 0156.1, ROTH)  
Ponceau S solution Ponceau S solution BioReagent, 0.1 % (w/v) in 5% acetic 
acid (Art Nr. P7170-1L, Sigma) 
Potassium Chloride ≥99, 5 %, p.a., ACS, ISO (Art Nr. 6781.1, ROTH) 
Potassium dihydrogen phosphate ≥99 %, p.a., ACS (Art Nr. 3904.1, ROTH) 
Potassium phosphate dibasic trihydrate (Art Nr. 16788-57-1, Sigma)  
 
S 
Sodium Chloride (Art Nr. 3957.1, ROTH) 
Sodium dodecyl sulfate, 10% (10%-SDS) (Art Nr. 155553-035, Gibco) 
Sodium dodecyl sulfate, 20% (20%-SDS) (Art Nr. 1057.1, ROTH) 
Sodium hydroxide (Art Nr. 1.06459.1000, Merck) 
Sorbitol (Art Nr. 6213.2, ROTH) 
Stempro-Accutase, cell dissociation reagent (Art Nr. A11105-0, Gibco) 
T 
TEMED GE health care (Art Nr. GE17-1312-01, Sigma) 
Trichloracetic acid (TCA) (Art Nr. 91228-500G, Sigma) 
TRIS PUFFERAN® ≥99, 9 %, Ultra Qualität (Art Nr. 5429.3, ROTH) 
Triton-X-100 (Art Nr. 3051.2, ROTH) 
Trypan Blue 0.5% (w/v) in PBS (Art Nr. L6323, Biochrom Ac) 
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Trypsin EDTA 1x (Art Nr. 594170-100ML, Sigma) 
Tween 20% (Art Nr. S413784432, Merck) 
Tween 40% (Art Nr. P1504 – 500ML, Sigma) 
Y 
Yeast Extract powdered, for bacteriology (Art Nr. 2363.5, ROTH)  
Yeast Nitrogen Base (YNB) (Art Nr. Y0626-2506, Sigma) 
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Media and Buffers list 
Table 2-1 Yeast Growth Media  
Yeast Peptone 
Dextrose (YPD) 
Plates: 12 g Glucose (2%), 12 g Peptone (2%), 6 g 
YNB (1%), are dissolved in 300 ml ddH2O with help 
of magnetic stirrer at room temperature (RT). The pH 
of solution is adjusted to (5.5) with 37% N HCl 
solution. The final volume is then completed to 600 ml 
with deionized and distilled (ddH2O). To prepare agar 
plates, a 10 g of Agar-Agar KobeI is added to the 
media solution. Media is then autoclaved at 121°C for 
15 min. Autoclaved media is poured into plates and 
left solidify overnight under sterile hood. Next 
morning, media plates are stored at -4oC and ready to 
use.  
YP stock: 12 g Peptone (2%), 6 g YNB (1%) are 
dissolved in 300 ml of ddH2O, with magnetic stirrer at 
RT. The pH is adjusted to (5.5) using 37% N HCl 
solution. The final volume is completed to 540 ml with 
ddH20 and media is autoclaved at 121°C for 15 min. 
The YP-stock can be stored at RT.  
YPD-rich (2% glucose): a 1:10 of 20% filter-sterile 
glucose is prepared in YP volume according to final 
amounts required for experiments, by this a YPD 
media with a final concentration (2%) of dextrose 
(glucose) is obtained. 
YPD-starvation (0.3% glucose): a 1:10 of 3% filter-
sterile glucose is diluted in YP according to volume 
required for experiments to obtain a final 
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concentration (0.3%) of glucose.  
YPD-G418 
Similar to YPD plates, except that the autoclaved 
media is left to cool to 50oC under continuous magnet 
stirring, then the media is supplemented with 200 
mg/L Genticin or any other selection antibiotics. 
Stirred 3 min with magnet to disperse the antibiotic. 
Media is now ready to be poured immediately in petri-
dishes. The plates are left to solidify overnight and 
stored at 4oC up to 1 month.  
Yeast Peptone 
Glycerol (YPG) 
YP-(0.3% glycerol): add 60 ml of 30% Glycerol 
(autoclaved 30% glycerol stock) – added after 
autoclave of 540 ml YP-Agar.  
Oleic acid induction 
media 
Plates: 0.17% Ammonium sulfate, 0.1% Yeast 
Extract, and 0.5% amino acid mixture. Next, 0.1% 
oleic acid (112 µl) is emulsified in 1 ml water and 
0.5% Tween 40 (0.5 g) and vortexed. Then all of the 
emulsified oleic acid is added to media content. The 
pH is adjusted to 6.0 and final volume is adjusted to 
100 ml with ddH2O. Two grams of Agar-Agar KobeI 
are added and media is stirred 5 min with magnet. 
Media is autoclaved at 121°C for 15 min and poured 
on plates. Oleic acid containing media should always 
be stored away from light overnight at RT, then store 
at 4°C for up to 4 weeks. Protect from light!  
Media: prepared the same way as the Oleic acid 
containing agar plates, except that no agar is added. 
Stored away from light at RT up to 3 weeks! 




(SD) - URA media 
Plates: 6 g YNB (Sigma), 0.5 g Aminoacid-URA, 12 g 
of water-free glucose (ROTH) are dissolved in 300 ml 
ddH20, by help of magnetic stirrer, and pH is adjusted 
to 6.0 with NaOH. The final volume is then completed 
to 600 ml with ddH2O and 10 g of Agar-Agar KobeI 
(ROTH) is added. Media is then autoclaved 121 oC for 
15 min and poured into petri-dishes (SARSTEDT). 
Plates can be left overnight to solidify in sterile hood 
and they can be stored at 4oC for later use up to 1 
month.  
Media: 6 g 0.1% YNB (Sigma), 0.5 g Aminoacid-URA 
are dissolved in 300 ml ddH2O by help of magnetic 
stirrer, and pH is adjusted to 6.0 with NaOH. Final 
volume is than completed to 540 ml by ddH2O and 
media is autoclaveed at 121oC for 15 min. Prior to 
experiment 20% glucose filter sterile stock is diluted 
in media to get an SD-URA with final glucose 
concentration of 2% glucose.  
 
Table 2-2 Yeast Competent cells and transformation buffer 
SORB Buffer 
500 ml: 100 mM LiOAc (5.1 g), 10 mM Tris-HCl pH 8.0 
(5 ml from 1 M stock), 1 mM EDTA pH 8.0 (1 ml from 
0.5 M stock), 1 M Sorbitol (91.1 g, molecular biology 
grade) dissolved in ddH2O. SORB buffer is sterile 
filterate and aliquoted into 50 ml falcons. The buffer 
can be stored at RT for up to 6 months.    
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PEG COMP Buffer 
100 ml: 100 mM LiOAc (1.02 g), 10 mM Tris-HCl pH 
8.0 (1 ml from 1 M stock), 1 mM EDTA pH 8.0 (200 µl 
from 0.5 M stock), 40% PEG-4000 (Sigma) dissolved 
in ddH2O. Sterile filterate buffer, can be stored at 4 oC 
for 6 months.  
Carrier DNA (salmon 
sperm single stranded 
DNA) 
200 mg ssDNA (Sigma) is dissolved in 20ml sterile TE 
Buffer (10 mM Tris–HCl pH 8.0, 1 mM EDTA pH 8.0) 
by vortexing or magnetic stirring in 50 ml falcon for few 
hours at 4oC. It is possible to use 25 ml wide bore 
Pipette to pipette DNA up and down until no DNA is 
seen. No sonication needed. The solution is can be 
aliquoted in volumes of 1 ml in 1.5 ml Eppendorf sterile 
tubes, then stored at – 20 °C. The carrier DNA must 
be boiled 5 min and chill immediately on ice before 
use. Denatured sssDNA can be boiled 3 - 4 times 
without significant loss of activity. 
 
Table 2-3 Genomic DNA isolation buffers 
gDNA lysis Buffer 
(LiOAc) 
200 mM LiOAc, 1% SDS in ddH2O. 
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Table 2-4 Antibody immunofluorescence reagents 
Paraformaldehyde 
fixation (10%) 
35 ml of 37% formaldehyde is added in a 50 ml falcon 
tube and the volume is adjusted to 50 ml with 1xPBS 
(Dulbecco). Aliquots into 5 ml volumes (in 15 ml 
falcons) can be saved and freezed at -20°C. Fresh 
aliquots are used in each experiment and stored for 
reuse at 4°C for up to 1 week. 
Permeabilization 
(0.5% Triton-100x in 
PBS) 
50 ml 1xPBS is added in 100 ml cylinder tube. A cut 
blue pipette tip (1000 µl) with scissor are prepared, 
and reverse pipetting technique is used to add 500 µl 
100% Triton-100x to the 50 ml 1xPBS. The solution is 
then stirred with magnet for 5 min and volume is 
adjust to 100 ml. Final solution is then stirred for 2 min 
at RT and stored in 100 ml bottles at RT for later use. 
Blocking solution 
(10% BSA) 
5 g BSA is added to 25 ml 1xPBS (Dulbecco). The 
tube should be inverted up and down to hydrate BSA 
powder. The solution is put at -20 oC and carefully 
observed to avoid freezing, this takes approximately 
10 min until all BSA powder is completely dissolved. 
The -20oC step can be repeated with increasing PBS 
volume between each 10 min at -20oC. It takes 15 – 
30 min max to dissolve all BSA. The final volume is 
then completed with 1xPBS to 50 ml, and the solution 
can be aliquoted into 2 ml volume. These aliquots can 
be stored at -20 °C for later use. 




Buffer (2% BSA) 
2.5 g BSA is added to 25 ml 1xPBS (Dulbecco). The 
tube should be inverted up and down to hydrate BSA 
powder and incubated in -20°C for 10 min. The 
solution is brought back to -20oC and carefully 
watched to avoid freezing till BSA powder is 
completely dissolved. The final volume is then 
completed with 1xPBS to 50 ml. The solution can be 
aliquoted into 2 ml volume and frozen at -20°C. 
1xPBS wash solution 
10x PBS stock solution: In 800 ml ddH2O: 80 g NaCl, 
2.0 g KCl, 14.4 g K2HPO4, 2.4 g KH2PO4 are 
dissolved. pH is then adjusted to 7.4 and a final 
volume of 1 L is obtained by addition of ddH2O. Final 
solution is sterilized by autoclaving at 121 oC for 15 
min and stored at RT. 
1xPBS: Prepare 1:10 in ddH2O and keep at RT. 
 
Table 2-5 Nanobody staining reagents 
Paraformaldehyde 
Fixation (4%) 
Commercial reagent (Affymetrix) 4% PFA in PBS can 
be directly used or a 3.7% PFA can be prepared as 
follows: 5 ml of 37% formaldehyde is added to 50 ml 
falcon tube and volume is adjusted to 50 ml with 
1xPBS (Dulbecco), mixed properly and saved in 
aliquots (5 ml aliquots in 15 ml falcons). PFA solutions 
can be stored at -20°C for longer times and fresh 
aliquots can be stored at 4°C and reused up to 1 
week. 
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Permeabilization  0.5% Triton-100x in PBS 
PBS-T 1 L: 1xPBS + 0.1% Tween 20 
Blocking solution (4% 
BSA in PBS-T) 
2 g BSA powder is dissolved in 25 ml PBS-T. First 
vortex so that PBS-T reach the BSA powder, then 
incubate the mixture for 10 min at -20oC to enhance 
the BSA to dissolve quicker. Volume is then adjusted 
to 50 ml, vortex, and aliquots prepared in 2 ml 
Eppendorf tubes. Aliquots can be store at -20oC and 
used once, then discarded after use. 
 
Table 2-6 Western blot and co-immunoprecipitation (CoIP) solutions and 
buffers 
1.5 M NaCl 
8.76 g NaCl is dissolved in 100 ml ddH2O and stored in 
50 ml falcon tube at RT. NaCl solutions should not be 
stored in Glass Containers.  
10% NP-40 stock 
A 1:10 dilution is prepared from 100% NP-40 (Sigma) in 
ddH2O and kept at RT. 
2 M DTT, -20oC stock 
frozen 
3.09 g DTT is added to 6 ml ddH2O, mixed properly and 
the final volume is adjusted to 10 ml. Stock solution is 
dispensed into 1ml aliquots (1.5 ml Eppendorf tubes) 
and stored at -20°C. The solution is stable for up to 1 
year. 
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1 M Tris-HCl stock (pH 
7,4) 
1 L: 121.14 g Tris (ROTH) is dissolved in 800 ml dH2O. 
pH is then adjusted to 7.0 with the appropriate volume 
of concentrated HCl. The final volume to 1 liter is 
adjusted with ddH2O. Solution is then autoclave and 
stored at RT. 
50 mM PMSF (freshly 
made in case of 
quantitative results or 
low abundant 
proteins. Otherwise, it 
can be stored at -20 
°C and reused for up 
to few month) 
In 50 ml Flacon tube: 0.174 g PMSF powder is weighed 
and 20 ml pure Ethanol is added to the PMSF. Solution 
is vortexed (intermediate speed), to dissolve PMSF. For 
safety precautions: all steps are performed under the 
hood with proper ventilation, because PMSF is 
hazardous. The PMSF should be always freshly 
prepared prior to use, because it is unstable in aqueous 
solution with a short half-life in aqueous solution (30 
min).   
25x Complete 
Protease Inhibitor  
One tablet is added to 1 ml ddH2O in 2 ml Eppendorf 
tube. The solution is vortexed and mix to dissolve the 
tablet. Another 1 ml ddH2O is added to obtain 25x 
Complete Protease Inhibitor cocktail and stored at -20 
oC. It can be used up to 3 times (3 freeze-thaw cycles) 
and it must be kept on ice after thawing. In some cases, 




20 mM Tris-HCl (1 M stock) , pH 7.4, 150 mM NaCl (1.5 
M stock), 2 mM EDTA (Commercial 0.5M stock), 1% 
NP40 (10% Stock Solution), 1 mM DTT (2 M DTT 
stock), 0.1 mM PMSF (50 mM Stock), 1x Complete 
Protease Inhibitor (25x stock freshly prepared)  





4x stock: 40% Glycerol, 240 mM Tris/HCl pH 6.8, 8% 
SDS, 0.04% bromophenol blue 
5% β-mercaptoethanol. Store at -20oC for longer 
storage. 
PBS-T 1 L: 1xPBS + 0.1% Tween 20. 
SDS Running Buffer 
(10x stock) 
1 L:  Dissolve 30.0 g of Tris-base, 144.0 g of glycine, 
and 50 ml of 20% SDS in 1000 ml of ddH2O. The pH of 
the buffer should be 8.3 (i.e. no pH adjustment is 
required). The running buffer should be stored at room 
temperature and diluted to 1X before use. 
 
Transfer Buffer (10x 
stock) 
1 L: 3.03 g Tris-base and 14.41 g Glycine are dissolved 
in 500 ml ddH2O 200 ml  Methanol are  make up to 
1000 ml. The solution is stirred with magnet and store 
in bottle at RT. 
Blocking Milk Buffer 
(5% Milk Buffer) 
50 ml: 2.5 g of Milk Powder is dissolved in 25 ml PBS-
T, vortexed, and then complete to 50 ml with PBS-T. 
Antibody Dilution 
Buffer (1% milk 
Buffer) 
The 1% milk buffer can be prepared from 5% Blocking 
Milk Buffer by dilution  in PBS-T. 
Wash Buffer (PBST, 
0.1% Tween20) 
1 L: 1xPBS + 0.1% Tween 20. 
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Lysis buffer (CoIP) RIPA buffer protocol (same Table). 
Wash buffer (CoIP) RIPA buffer protocol (same Table). 




















Materials and methods 
 
 29 
Table 2-7 Antibodies list 
Antibody (Clone, 
company) 




Polyclonal (rabbit) 1:500 / 10% FA 24316 
ACAA1 (ag297 
,Proteintech) 
Polyclonal (rabbit) 1:500 / 10% FA 12319-2-AP 
PMP70 (clone 70-




1:500 / 10% FA SAB4200181 
PEX14 (ag0932 
,Proteintech) 
Polyclonal (rabbit) 1:500 / 10%FA 10594-1-AP 




1:100 / 10%FA 611113 













Nanobody 1:50 / 4%FA gba647n-100 









































Abberior 2C-STSED microscope (Abberior) 
AxioCam HRm (Zeiss) 
Biophotometer Plus (Eppendorf) 
Centrifuge 5415 D (Eppendorf) 
Fastblot B44 transfer apparatus (Biometra) 
GPR Centrifuge (Beckman) 
Imager.M1 microscope (ZEISS) 
ImageQuant LAS-4000 (GE Healthcare) 
Standart Power Pack P25 (Biometra) 
Thermomixer compact (Eppendorf) 
 
Other materials (A-Z) 
Blotting paper (Art Nr. 4033385, In-house supply) 
Cell scraper 25cm (SARSTEDT, Inc USA) 
Cell STAR 12-well cell culture plate, sterile, with lid (Art Nr. 665.180, CellSTAR) 
Cell STAR 24-well cell culture plate, sterile, with lid (Art Nr. 662.160, CellSTAR) 
Cover slides 76x26 mm (Thermoscientific) 
Cover slips 12 mm (Thermoscientific) 
Nitrocellulose membrane AmershamTM ProtranTM 0.45 mm (Art Nr. 10600002, GE 
Healthcare) 
Petri dishes for agar plates (Art Nr. 82.1472, SARSTEDT) 
 
 




Preparation of Yeast competent cells  
Competent yeast cells were prepared according to a previously described 
method [99].  
 
Yeast genomic integration 
Genomic integration is used to integrate or replace genetic materials in the 
genome of yeast cells by homologous recombination [100]. Universal cassettes 
have been developed to make genomic integration a straight-forward procedure, 
which involves a PCR amplification step of selection marker and desired genetic 
material (tags or promoters) from cassettes using primers that include genetic 
homologous recombination sequence similar to insertion or deletion sites in the 
genome, more details about the technique can be found in this reference [100]. 
To delete pex3 in GFP-PEX35 overexpression strain (natNT2-TEFprom-
GFP-PEX35), a compatible deletion cassette was used (pFA6a – hphNT1) from 
[100]. PCR of 25 µl was prepared using the HiFi-KAPA polymerase kit (according 
to manufacturer protocol with a High-Fidelity HIFI buffer; PCR program according 
manufacturer protocol with Tm = 60°C). Only 1 µl of PCR volume was used to 
check PCR results, and rest was saved for transformation step. Primers used for 
deletion are listed in (Table 2.8). 
Table 2-8 Primers sequence 





CACTAAAAGG ATG  
CGTACGCTGCAGGTCGAC  






5ATA TAT ATA TAT ATT CTG GTG TGA GTG TCA GTA 











Yeast transformation  
Transformation of yeast cells was done according to [99]. Yeast cells were heat-
shocked for 15 min. In case plasmid or PCR product transformed contained 
auxotrophic marker cells were sedimented (2 - 3 min at 500 xg), resuspended in 
200µl sterile ddH2O, and plated directly on selection plate. Only if the plasmid or 
PCR product being transformed contained an antibiotic selection marker, cells 
were resuspended in YPD and left to grow at 30 oC (180 rpm) for 4 – 6 hours, 
before spread on a plate with the appropriate dominant selection marker.  
 
Nanobody staining and STED microscopy 
Strains were transformed with EYFP-SKL (plasmid PST1219) and analyzed as 
described [101] using GFP nanobodies coupled to Atto647N (Chromotek, 
Planegg-Martinsried), except that coverslips were not washed prior to use. Slides 
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were analyzed on a custom-made STED setup described previously [77]. Images 
are shown as unprocessed raw data. The size of yeast peroxisomes was 
calculated from the images by ImageJ. Peroxisomes were selected manually and 
the center of mass for each peroxisome was used to find the Full-Width-Half-
Maximum (FWHM), using a “FWHM_Line.ijm” (free marcro designed by Vitha, 
Stanislav) on ImageJ (NIH). Data were plotted and t-statistics hypothesis tests 
were done on OriginPro v9.1.  
 
Oleic acid growth assays 
Yeast growth on oleic acid plates was described before in [54], spotting was 
done as follows: overnight startup cultures in YPD starvation media (0.3% 
glucose) were incubated at 30 °C for 16 hours and fresh inoculums were 
collected in the same medium and left to grow for 9 more hours into mid-log 
phase. Cultures were spun down, washed once with sterile distilled water and re-
suspended in water at equal OD600 of 1. Four times 2 µl spots of serially diluted 
cells spotted for each strain on oleic acid, YPD and YP-Glycerol plates. Plates 
were incubated at optimal yeast growth conditions for two days followed, while 
oleic acid containing plates were incubated another ~ 14 days at 4 °C prior to 
digital imaging.  
To obtain growth curves overtime of yeast strains in oleic acid the [28] 
protocol was adapted and modified as follows: overnight yeast pre cultures in 
YPD starvation were inoculated in fresh YPD starvation media for a 9 hours’ 
incubation period, till they reached mid log phase. Mid log yeast cultures were 
collected, washed twice in ddH2O sterile water and resuspended in water again. 
OD600 was measured and yeast cells were inoculated at 0.1 OD600 in oleic acid 
containing medium. To construct a growth curve under oleic acid growth 
conditions yeast cells were spun down, supernatants were saved to measure 
oleic acid consumption, and cells were washed twice with water prior to OD600 
measurements. Data analysis was done using Office Excel. 
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Amino acid intracellular metabolomics 
For quantitative analysis, equal OD units of yeast samples were collected from 
equal cultures of yeast growing logarithmically or stationary in synthetic defined 
media. Intracellular metabolites were extracted using freeze thaw in 50% 
methanol at -80oC according to [102]. Cell pellets were discarded and 
supernatants were saved for solvent speed vacuum to get rid of methanol (at 
40oC for 30 min) and extracted amino acids were re-suspended in water. Amino 
acid concentrations were analyzed using an Onken HPLC analyzer (Onken 
Gmbh). Results were interpreted in (log2)-fold of change compared normalized to 
wild-type, and a ∆pex3 (peroxisome deficient) was included strain to serve as 
negative control. Additional kanamycin tagged wild-type strain was used to 
evaluate interference from selection marker genes.  
 
DNA cloning and plasmids 
PEX13-mGFP and PEX2-mCitrine have been described previously [103]. PEX12 
cDNA was used to clone PEX12 into EYFP-C1 (Clontech) or TagRFP-C1 
vectors. Sticky end PCR cloning of PEX12 using HindIII and EcoRI restriction 
sites. The primers sequences used in PEX12 cloning are shown in Table 2.7).  
Restriction, ligation and bacterial transformation were done according to NEB 
(England) protocols. Positive clones were identified by restriction digestion and 
sequencing. DNA sequencing was done using the BigDye kit (ABapplied 
Biosystems) and analyzed by a sequencer (chromatograph analyzer). 
 
Patient-derived skin fibroblast 
Eight ZSS patients from seven different complementation groups (PEX1, PEX2, 
PEX5, PEX6, PEX10, PEX12 and PEX13) were included in the study. The 
diagnosis had been established by characteristic clinical and molecular findings 
[40, 103, 104].  A written informed consent was obtained from guardians of all 
patients. 
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Cell culture, transfection and immunofluorescence 
Cells were cultured in low glucose Dulbecco’s Modified Eagle Medium (DMEM) 
medium (Biochrom GmbH, Germany) supplemented with 1% Pen/Strep (100 
units/ml Penicillin and 100 µg/ml Streptomycin, material section), 1% (w/v) 
glutamine (material section) and 10% (v/v) Fetal Bovine Serum (FBS) in 5% CO2 
at 37°C. For all experiments cells were detached with Accutase® (Life 
Technologies, material section), washed once with PBS Dulbecco (Biochrom 
GmbH, Germany), and counted using Neubauer hemocytometer (material 
section), according to manufacturer protocol. Equal densities of cells for all 
conditions and cell lines were seeded and cell culture conditions were kept 
constant to ensure maximal reproducibility. In Rescue experiments, cells were 
transfected using Effectene® transfection reagent (QIAGEN) according to 
manufacturer protocol. Medium with transfection reagent was changed after 6-8 
hours and cells were incubated for 24 hours before being used in downstream 
experiments. For immunofluorescent detection of peroxisomal catalase [40], a 
rabbit polyclonal antibody against catalase (Table 2.7) was used to probe 
peroxisomal catalase and a donkey anti-rabbit secondary IgG antibody 
conjugated to Cy3 Rhodamine dye (Jackson ImmunoResearch, 1:400) for 
fluorescent microscopy detection. For STED experiments cells were fixed using 
10% paraformaldehyde freshly prepared (Table 2.4) from a 37% formaldehyde 
stock (material section), blocked in 10% Bovine Serum Albumin (BSA) in PBS, 
and permeabilized using 0.5% Triton-100x in PBS (Table 2.4). The following 
primary antibodies were used: monoclonal mouse anti- PMP70 (Table 2.7), 
polyclonal rabbit anti-PEX14 (Table 2.7), polyclonal rabbit anti-catalase (Table 
2.7), polyclonal rabbit anti-ACAA1 (Table 2.7), monoclonal mouse anti-DLP1 
(Table 2.7), monoclonal mouse anti-GFP (Table 2.7), and monoclonal mouse 
anti-Myc (Table 2.7). Primary antibodies were incubated in 1%BSA in PBS for 1 
hour at 37oC. The proteins were tagged with indirect immunostaining using the 
following secondary antibodies diluted in 1% BSA in PBS: Sheep anti-mouse 
immunoglobulin (Dianova) coupled to Atto594 (Atto-TEC, Table 2.7) or KK114 
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(Abberior, Table 2.7). Secondary antibodies were added in 1% BSA in PBS for 1 
hour at 37°C. Cells were washed three times (10 min each) in PBS between 
each antibody incubation and mounted on Mowiol mounting medium.  
 
Nanoboosted GFP and RFP in HeLa cells 
HeLa cells were cultured in low glucose DMEM similar to HSF cells in 5% CO2 at 
37°C and trypsin (materials section) was used to detach adherent cells. Single 
transfection experiments were done using Effectene; however, for co-transfection 
LipofectamineLTX PLUS (Thermofisher) was used according to manufacture 
protocols. For nanobody staining the Chromotek nanobody protocol was used 
(Table 2.5) and following nanobody boosters were used GFP-Atto647N and 
RFP-Atto594 nanobooster (Table 2.7). 
       
Widefield microscopy  
Widefield images were obtained using the 100x oil objective (1.3 NA) of a Zeiss 
Imager M1 fluorescence wide field scope microscope equipped with the Zeiss 
Axiocam HRm Camera and Zeiss Axiovision 4.8 acquisition software. ImageJ 
software (NIH, USA) was used for linear contrast enhancement of images, 
cropping and scale bars. Images were arranged in figures using Adobe Illustrator 
software. 
 
STED microscopy setups  
A custom made gated STED (gSTED) setup was used for single as well as two 
color imaging as in previous studies [77].  For the RFP/GFP co-transfection 
experiments with nanobody labeling a commercial two color STED setup 
(Abberior™ Instruments) was used instead. Both setups use a pulse gated 775 
nm doughnut shaped STED laser beam, 590 nm laser to excite Atto594 dyes and 
a 640 nm laser to excite Atto647N/KK114 dyes. Crosstalk was always measured 
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as previous using single dye labeled samples [77]. Imspector acquisition 
software (written by Dr. Andreas Schönle, Max Planck Institute for Biophysical 
Chemistry, Göttingen, Germany, available via Max-Planck-Innovation GmbH, 
Munich, Germany) was used on both setups and acquisition parameters kept 
constant for quantitative measurements. To visualize images in figures, raw 
images were linearly scaled in ImageJ and arranged with Adobe Illustrator.  
Subdiffraction size analysis  
Raw data were handled in ImageJ, smoothed with 1 pixel Gaussian function and 
line scans were obtained using the line drawing tool in ImageJ through structures 
of interest. Line scan data were copied into Matlab (www.mathworks.com) and 
processed for data fitting (Gaussian function) using custom-made automated 
routine (see Appendix 6.1). Histogram and boxplot diagrams and statistics were 
produced and calculated in Matlab. 
 
CellProfiler: automated STED analysis  
Images were analyzed using a CellProfiler (www.cellprofiler.org) pipeline 
designed based on previously published methods [98]. Raw images were 
smoothened using average 3x3 ImageJ smooth function. Gaussian blurring with 
a diameter of 100 nm was applied to images in CellProfiler, in order to identify 
single ghost structures into clusters (objects) within this diameter. Blurred images 
were divided into 50x50 pixel blocks and adaptive Maximum Correlation 
Threshold (MCT) algorithm (lower limit 0.05 – upper limit 1) was computed for 
each block. Shape and local maxima were used to distinguish boarders, and to 
identify and declump grouped clusters. Holes within identified objects were filled 
after thresholding and declumping.  
To find individual protein clusters within cluster groups, raw images were 
thresholded by computing two-class global Otsu thresholding (upper limit: 0.12 – 
lower limit: 1) with automatic smoothing settings. Intensity and local maxima were 
used to identify and declump clusters. Relating clusters before and after 
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Gaussian using Relate object module allowed us to identify children clusters 
(PMP70 clusters in the original STED image) per each parent (Ghost clusters in 
the blurred image). Other object features, like cluster area and eccentricity for all 
clusters were also calculated and saved to a spreadsheet file for further data and 
statistics analysis. Only blurred ghost clusters (Parent objects) with positive 
PMP70 cluster values from STED image (children objects > 0) were included in 
the downstream analysis. The analysis parameters were implemented in an 
automated pipeline in CellProfiler to ensure unbiased analysis. Boxplot, bar 
graphs and t-statistics tests were done using OriginPro v9.1 software and figures 
were arranged in Adobe Illustrator. Analysis was done on at least 3 independent 
experiments. However, for a number of conditions, as indicated in the figure 
legends, the cells have very slow division rates, and therefore only two 
independent experiments were performed.  
 
CellProfiler: ghost peroxisomes quantification  
Images were acquired by the M1-Imager wide-field microscope with 100x oil 
objective (semi-automated analysis). Images were saved in ImageJ as color 
images (RGB). Color images were separated into respective channels in 
CellProfiler and named accordingly. The nuclei and peroxisomes were found and 
segmented by a primary object identification module, whereas cell borders (semi-
automated analysis) were manually defined with the manual free drawing object 
module. Peroxisome signals were thresholded using Otsu threshold and 
segmented by intensity automatic settings. Nuclei were smoothened with 
Gaussian filter prior to segmentation to remove nuclei speckles and improve 
segmentation efficiency. Finally, a relate object module was implemented to 
quantify the peroxisome number per cell. Data analysis was done using 
OriginPro v9.1 statistics software. Figures were arranged on Adobe Illustrator.  
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Protein extraction by non-ionic detergents 
Non-ionic detergent-based cell lysis, protein extraction from mammalian cell 
culture and SDS-PAGE techniques have been described previously [105]. Cells 
were lysed and protein extraction was performed as follows: cells were washed 
once with 1x PBS, trypsinized for 5 min at 37oC. After trypsinization, FBS 
containing DMEM media was added to block trypsin activity. Cells were then 
sedimented by centrifugation (1000 rpm, 15 min, 4 oC), washed once with 1x 
PBS. Then, RIPA buffer (Table 2.6) was added to cells (incubated 30 min at 4oC 
with vortex max. speed). Cell debris were removed by 14000 xg centrifugation 
and supernatant, which contain lysates, was transferred to new low protein 
binding polymer 1.5 ml cups. Total protein quantification using a commercial BCA 
assay kit (materials) was directly done and proteins were diluted to a final protein 
concentration in RIPA buffer. Finally, 1x SDS-Laemmli buffer (4x stock: 40% 
Glycerol, 240 mM Tris-HCl pH 6.8, 8% SDS, 0.04% bromophenol, 5% β-
mercaptoethanol, Table 2.6) was used to denature protein and denaturation was 
completed by incubating at 70oC for 5 min. Protein solutions were directly used 
for Western blot or snap frozen by liquid nitrogen until later use.    
Protein was loaded and mobilized on self-made SDS polyacrylamide gels 
12% and 4% resolving and stacking gels, respectively, as previously described 
[106]. Protein pre-stained reference ladder (Thermo fisher®, P20199) was used 
as reference for protein size and migration. Equal protein amounts and volumes 
were loaded to avoid incorrect quantification errors. Gels were run in Bio-Rad 
Western blot chambers filled with SDS running buffer (Table 2.6) at 0.5mA/cm2 
from the begin of entry into the resolving gel. Running speed was always lower in 
the stacking gel to allow efficient stacking of proteins and overall running time 
was less than 1 hour to avoid heat degradation of proteins. Semi-dry membrane 
transfer (blotting) of proteins was done on nitrocellulose blotting membrane 
(material section) in 1% SDS supplemented Transfer buffer (Table 2.6) at 
1.2mA/cm2 for 1 hour 15min. To check transfer efficiencies NC blots were 
treated with commercial Ponceau S solution (Sigma, P7170-1L) to visualize total 
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proteins. Membranes were blocked by 5% Milk blocking buffer in PBS-T (1xPBS, 
0.1% Tween 20%, Table 2.6) for 1 hour at RT. Prior to primary antibody 
incubation membrane blots were cut into multistrips to detect proteins of interest 
simultaneously, in order to increase quantitative output of our Western blot 
technique [107]. Membranes were probed using the following antibodies: PMP70 
(Table 2.7) and GAPDH loading control (1:5000, ab2948, Sigma) diluted in 1% 
milk antibody dilution buffer (Table 2.6) and incubated overnight with rocking at 
4oC. Excess primary antibodies were then washed three times by PBS-T buffer of 
10-minute wash durations. Secondary antibody conjugated to horseradish 
peroxidase were applied and diluted in 1% milk dilution buffer for 1 hour at RT, 
followed by another washing step as previous. ECL or ECLplus chemilumincent 
kits (Thermofisher) were used to detect protein bands by immersing blots in ECL 
or ECLplus buffer for 3min in dark. Membrane blots were then put in transparent 
files and the protein ladder was marked by fluorescent permanent marker to 
visualize bands with a chemilumincent cameras. 
 
Blot imaging and data analysis 
Membranes were imaged by a chemilumincent doc system (LAS4000, Siemens). 
For quantitative purposes, exposure time was kept at a minimum to avoid signal 
saturation; however, exposure time was above 10 seconds to ensure linearity of 
detectors. Bands signals were quantitated (for densitometry) using Image Studio 
Software (LI-COR Biosciences). For each sample, the bands were normalized to 
GAPDH and results of at least three independent replicate experiments were 
included in the final analysis.  One way anova statistics analysis was carried out 
for induction experiment using excel and the R-square statistics software to 
calculate F-statistics. 
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GFP-trap co-immunoprecipitations experiments  
HeLa cells were seeded and cultured in 10 cm dishes at a density of 2.2 
million/x106, incubated overnight at 37oC and 5% CO2 in low glucose DMEM 
medium. Next day, cells were transfected using Effectene (QIAGEN, UK) 
transfection reagent according to manufacturer protocol. Twenty-four hours post 
transfection; cells were scrapped in 1 ml cold PBS using sterile cell scraper 
(25cm, SARSTEDT, Inc USA) and harvested according to GFP-trap A 
(Chromotek) manufacturer protocol. Fresh RIPA buffer (20 mM Tris-HCl, 150 mM 
NaCl, 1 mM EDTA, 1x Roche cocktail inhibitors, and 0.1 mM PMSF; Table 2.6) 
was added to lyse cells. Cells were resuspended in RIPA using 0.45 mm x 0.5 
mm needles and a 2 ml syringe. GFP trap A beads were equilibrated according 
to the manufacturer by dilution buffer B (Table 2.6) supplement with 1x Roche 
cocktail inhibitors. Lysates were incubated at 4 degrees for 90 min for trapping 
GFP by tumbling end over end. Bound beads were washed two times in dilution 
buffer and additional wash in wash buffer 2 (Table 2.6). Some lysate and 
unbound fraction were always saved for Western blot analysis. GFP-Protein and 
bound complexes were eluted from beads by boiling in 2x SDS buffer for 5min. 
One tenth of lysate volume of bound and unbound fractions was loaded on SDS-
PAGE. Western blot SDS-PAGE analysis was carried out as previously. 
Multistriped membranes IP lanes were probed using GFP (Abcam, Table 2.7) 
and PMP70 (Sigma, 1:500; Table 2.7). Proteins of interest were detected with 
HRP-conjugated donkey anti-rabbit IgG antibody (1:5000, Invitrogen) and donkey 
anti-mouse IgG antibody (1:5000, Invitrogen), and visualized with Pierce ECLplus 










The results described in the following sections are part of two unpublished 
manuscripts: 
1. Kareem Soliman, Fabian Göttfert, Hendrik Rosewich, Jutta Gärtner, Sven 
Thoms “Super-resolution imaging reveals the subdiffraction structure of 
wild-type and Zellweger Syndrome Spectrum peroxisomes” (in 
preparation). 
2. Ido Yofe, Kareem Soliman, Silvia G Chuartzman, Bruce Morgan, Tobias P 
Dick, Sara J Cooper, Christer S Ejsing, Maya Schuldiner, Einat Zalckvar, 
Sven Thoms “PEX35 a novel regulator of peroxisome biogenesis” (under 
revision). 
 
3.1. Characterization of PEX35: a novel regulator of 
peroxisome abundance 
 
Super-resolution microscopy demonstrates opposing effects for loss or 
overexpression of YGR168C 
The deletion and overexpression of YGR168C have been found to decrease 
numbers of peroxisomes per cell (Yofe et al, unpublished). Confocal microscopy 
revealed enlarged peroxisomal size in both deletion and overexpression of 
YGR168C. To analyze the effect of YGR168C on peroxisomes in more details, 
the peroxisomal size and morphology were analyzed by STED microscopy. 
Yeast strains were transformed with a GFP variant (EYFP-SKL) that is targeted 
to peroxisomes and cells were labeled with nanobodies directed against GFP. 
The size of 71 wildtype peroxisomes was measured and mean analysis revealed 
a peroxisomal subdiffraction diameter of 174 nm (± 8 nm s.e.m.) (Fig.3.1A).  
Next, STED microscopy revealed a subdiffraction phenotype of the mutant 




strain, but their sizes were slightly, but not significantly increased. However, 
peroxisomes in the overexpressing strain (natNT2:TEFprom-PEX35 strain) 
revealed a convoluted subdiffraction phenotype of enlarged peroxisomes, which 
in some cases indicate hyper-vesiculation of tiny peroxisomes that clump 
together, which appear as single big peroxisomes when visualizing cells by 
confocal microscopy (Fig. 3.1B).  
 
Figure 3.1 STED subdiffraction size and phenotype analysis of yeast 
peroxisome in Pex35 mutant strains.  
STED imaging and analysis was done on yeast strains expressing EYFP-SKL and 
labeled with nanobody coupled to Atto647N. (A) STED line scan analysis of 
peroxisome size from yeast wildtype and ∆pex35 strains. The boxplot indicates 
subdiffraction sizes of peroxisomes measured by FWHM from Gaussian fit line 
scans. t-statistics analysis indicated (n.s. not significant, at P < 0.05). (B) STED 
images of peroxisomes (EYFP-SKL) of the O.E-PEX35 strain. Images are 
smoothened with a 3x3 average filter. Scale bar = 500 nm.  
 
Based on these observations the YGR168C a regulator of peroxisome 
number and size in yeast. In addition to that, the associated YGR168C 




novel role of the YGR168C protein (Ygr168c) in peroxisomal membrane 
vesiculation. 
 
YGR168C is a new PEX gene (PEX35) 
Since Ygr168c has shown to be a new peroxisomal protein with signs of a 
peroxin, it was named Pex35. Most strains with defects in pex genes show 
growth defects when plated on media with oleic acid as sole carbon source [28]. 
Strains with a ygr168c gene deletion showed a reduced growth and reduced 
halos, representative of a lack of oleic acid consumption, while growth on 
glucose media was not affected (Fig. 3.2A). However, overexpression of the GFP 
tagged isoform (TEFprom-GFP-PEX35) showed a strong phenotype suggesting 
that N-terminal tagging aggravates the phenotype (Fig. 3.2A). Growth curves on 
oleate as a sole carbon source confirm this finding: The growth rate of ygr168 
and TEF1prom-GFP- YGR168C was higher than pex3 and less than the control 
(Fig. 3.2B). Quantitative assessment of oleate at the end point of the growth 
assay showed that mutant cells indeed utilized less of the available oleic acid 
(Fig. 3.2C). The loss of peroxisomal punctate localization in peroxisome defect 
strains (e.g. ∆pex3) is a unique characteristic of bona-fide peroxisomal 
membrane proteins. In order to prove that it is a bona-fide peroxisomal protein, 
the expression of GFP-Ygr168c was tested in the absence of pex3. In pex3, 
GFP-Ygr168c expression is strongly reduced and the residual GFP signal is 
distributed in the cytosol and the ER (Fig. 3.2D), which further confirms that 





Figure 3.2 YGR168C is a new peroxin (PEX35).  
(A) Oleic acid spotting assay of indicated strains (top) and their growth on YPD 
control plates (bottom). (B) Growth curves in oleate medium over 4 days of 
wildtype, ∆pex3::KanMX6, ∆pex35::KanMx6, and TEFprom::natNT2-GFP-
PEX35 (GFP-PEX35) strains. (C) Oleic acid consumption of the yeast strains, t-
statistics are indicated with their significance (**, P<0.01). (D) 
TEFprom::natNT2-GFP-PEX35 (GFP-PEX35) localization in the wildtype 





Characterizing the molecular function of PEX35 
SGA genetic lethality screen indicated a synthetic defect of PEX35 and many 
genes of amino acid metabolic pathways, especially that of the amino acids 
arginine and lysine (Yofe et al, unpublished). This initiated a metabolome study 
of yeast amino acids of ∆pex35 and GFP tagged overexpression strains, in 
combination with wildtype and a peroxisome defect strain (∆pex3) as control 
strains. Metabolome analysis revealed altered amino acid levels in the ∆pex3 
strain, and in both Pex35 overexpression and deletion strains (Fig. 3.3). The 
changes in the arginine and citruline levels were significant: arginine was ~ 90 
percent reduced in TEFprom-GFP-PEX35  strain and slightly (~ 1.65 fold) 
increased in the ∆pex35 strain, whereas citruline was only detectable in the 
TEFprom-GFP-PEX35 strain (Fig. 3.3). Additionally, alanine and lysine levels 
were altered in the ∆pex3 strain, which emphasizes the role of peroxisomes in 





Figure 3.3. Intracellular amino acid metabolome analysis.  
HPLC intracellular metalomics analysis in wildtype (n=3), ∆pex3 (n=3), ∆pex35 
(n=2), GFP-PEX35 (n=3). Arrows indicate altered amino acids in mutant strains 
compared to the wildtype control strain and the t-test statistics calculated and 







3.2. Characterization of human peroxisomes 
Peroxisome subdiffraction structure in normal and proliferating condition 
Human peroxisomes appear as spherical or elongated structures distributed 
across the whole cytoplasm when imaged by diffraction-limited fluorescence 
microscopy (Fig. 3.4A). To test whether super-resolution microscopy could 
resolve the peroxisomal membrane relative to the lumen, the peroxisomal 
membranes of HSF cells were stained with anti-PEX14 antibodies and secondary 
antibodies coupled to Atto594. Only STED microscopy could reveal the 
subdiffraction membrane-vs.-lumen arrangement (Fig. 3.4B,C). The estimated 
diameter of peroxisome appeared to be ~250 nm in the confocal image, 
measured by full FWHM of the Gaussian fitted line scan (see material and 
methods; Fig. 3.4D). However, using STED and analyzing the same position of 
the peroxisome structure the diameter was only ~ 100 nm, as measured by the 
distance between the peaks of the Gaussian fitted line scan (Fig. 3.4E). 
Quantification analysis of the diameter of 90 peroxisomes labeled with PEX14 
and KK114 coupled secondary antibodies revealed a mean peroxisomal 






Figure 3.4 STED nanoscopy reveal peroxisome membrane and lumen. 
(A) Widefield image of human skin fibroblast peroxisomes probed with 
polyclonal rabbit anti-PEX14 antibody and labeled with secondary antibodies 
coupled to the Atto594 dye. Scale bar = 5 µm. (B-C) Confocal and gSTED of the 
same peroxisomal structure. (D-E) Line scan analysis (Dashed lines).  (F) 
Histogram of subdiffraction size of peroxisomes immunostained with anit-PEX14 
and labeled with KK114 conjugated to secondary antibodies (n = 90) measured by 
distance from two maxima of two component Gaussian fit. Peroxisome mean 
diameter (dmean) = 98.1 ± 1.8 nm (s.e.m.)  
 
To visualize the peroxisome matrix, two-color STED imaging was used on 
peroxisomal membranes decorated with anti-PMP70 together with anti-catalase 
(CAT1) or anti-acetyl-CoA acyltransferase1 (ACAA1) antibodies to label the 
matrix (Fig. 3.5A,D). Peroxisomal membrane profiles in the microscopic plane 
were detected and the matrix enzymes CAT1 or ACAA1 were located within this 




showed matrix proteins peaks at the center of peroxisome membrane dips (Fig. 
3.5C,F). Taking into account the poor Z resolution of the used STED microscope, 
it is remarkable that we were still able to observe PMP70 only at the lateral side 
of peroxisomal membrane and matrix inside the membrane of peroxisomes  
 
Figure 3.5 Two-color STED nanoscopy of peroxisome membrane and matrix.  
HSF cells double immunofluorescence (A) Monoclonal anti-PMP70 labeled with 
KK114 secondary in red (left), polyclonal rabbit anti-Catalase (anti-CAT1) 
labeled with Atto594 coupled secondary in green (middle), and a merged image 
of both (right). (B) Blow-up of box in (A). (C) Gaussian fit of the line scan 
marked in (B). (D) Monoclonal anti-PMP70 labeled with KK114 secondary in red 
(left), polyclonal rabbit anti-3-Ketoacyl thiolase (anti-ACAA1) in green (middle), 




Gaussian fit of the line scan marked in (E). Images were smoothened by 3x3 
average filter and linearly scaled. Scale bar = 500 nm.  
Next, the structure of hyper-tubulated peroxisomes induced by the 
overexpression of PEX11beta were analyzed by STED microscopy. PEX11beta-
Myc expression in HeLa cells showed hyper-tubulated membrane morphologies 
in most of the cells 24 hours after transfection (Fig. 3.6A). STED microscopy 
revealed the subdiffraction size of hyper-tubulated structures to have a mean 
diameter of 91.8 nm ± 20.6 nm in comparison to control peroxisomes (HeLa cells 
without PEX11beta overexpression immunostained with anti-PEX14 antibody), 
which shows a mean diameter of 94.8 ± 21.8 (±SD) (Fig. 3.6B,D). In addition, 
vesicular peroxisomal structures were also found that appeared to undergo 
fission (Fig. 3.6C). The data indicates no change in the peroxisomal diameter 
upon PEX11beta overexpression in vivo (Fig. 3.6E). 
 
Figure 3.6 STED subdiffraction imaging of hyper-tubulated peroxisomes.  
 Peroxisome proliferation was induced by overexpression of PEX11beta 
membranes. (A) Raw STED overview image of HeLa cell overexpressing 
PEX11beta-Myc fusion 24 hours after transfection, probed with a monoclonal 
anti-Myc antibody and labeled with a secondary antibodies conjugated to KK114 
dye. (B) Blow up of a hyper-tubulated PEX11beta-Myc structure. (C) Another 
blow up of hyper-tubulated PEX11beta-Myc structure and arrow indicate a 
vesicle like structure. (D) Boxplot shows the diameter distribution of n = 74 anti-




peaks of Gaussian fit membrane profiles, and diameter of n = 88 PEX11beta-Myc 
structures (tubules) measured by FWHM of the Gaussian fit (in nm). The mean 
diameter (dmean) = 94.8 ± 21.8 nm and (dmean) = 91.8 nm ± 20.6 nm (±SD), 
respectively. Scale bar 500nm. (E) Model cartoon indicating PEX11beta effect on 
peroxisomal membrane thickness. Model 1 suggests that PEX11beta induce 
peroxisome elongation without constricting peroxisomal membranes (initial 
peroxisome diameter “d0” is equal to diameter of induced peroxisomes “dinduced”). 
Model 2 suggests that PEX11beta not only elongates peroxisomal membrane, but 
leads to membrane constriction and therefore the diameter of peroxisomes 
induced by PEX11beta is less than non-induced peroxisomes.    
 
DLP1 and MFF localization on peroxisomes at the nanoscale 
Peroxisomes proliferate by division employing a fission machinery that is shared 
with mitochondria [110]. In this study, the arrangement of two important fission 
proteins, DLP1 and MFF, have been examined by super-resolution microscopy. It 
was previously shown that a mutated form of DLP1 is able to form helical rings 
around constricted mitochondria and endoplasmic reticulum membranes [111]; 
however, such ring structures have not been reported with wild-type DLP1 in 
vivo.  Anti-DLP antibody was used to visualize endogenous DLP1 in HSFs. 
Mitochondria were labeled with antibodies against the outer membrane protein 
TOM20 as a non peroxisomal control. By this approach, not only the DLP1-
puncta along the mitochondrial membrane were revealed, but also rare ring 
structures and half-ring structures could be seen on constricted and invaginated 





Figure 3.7 Mitochondrial wtDLP1 ring structures on mitochondrial 
constricted and invaginated membranes (arrow).  
HSF cells immunostained with anti-DLP1 and anti-TOM20, labeled with Atto594 
anti-mouse and KK114 anti-rabbit secondary antibodies, respectively. (A) STED 
image overview of one cell. (B-G) Blow-ups of the boxes in (A). Scale bar 200 
nm. 
When analyzing peroxisomes, rare constricted peroxisomal membranes 
that have DLP1 were found, but did not reveal DLP1 ring structures (Fig 3.8A). 
DLP1 was also associated with peroxisome membrane tips (Fig. 3.8B). It has 
previously been observed with diffraction-limited microscopy that DLP1 localizes 
to peroxisome tips and constriction sites of elongated peroxisomes [34]. 
However, diffraction-limited microscopy proved that it can easily provide 
misleading information about the localization of DLP1 on peroxisomes:  Fig. 3.8D 
shows a DLP1 that appears to be located at a constriction or fission site of the 
peroxisome. Using STED, we had to classify these DLP1 puncta as not 
associated with the peroxisome (Fig. 3.8E). Taking advantage of this increase in 
resolution, a quantification analysis of DLP1 puncta associated with peroxisomes 
has been carried out. Most of peroxisomal DLP1 (89%) was found at membrane 
tips of peroxisomes and 11% were localized at invaginated or constricted 
membranes (Fig. 3.8F). To complement the image of peroxisomes undergoing 




Subdiffraction structures of GFP-MFF, marking membrane division sites of 
peroxisomes were identified (Fig. 3.8G,I). 
 
Figure 3.8 STED nanoscopy of DLP1 and MFF at peroxisomal constriction 
sites.  
 (A-B) HSF cells double immunofluorescence of polyclonal anti-PEX14 labeled 
with KK114 secondary (red channel, left) and monoclonal anti-DLP1 labeled with 




image of PEX14 and DLP1. (E) STED scan of the image in (D). (F) Pie plot of 
anti-DLP1 localization on membrane tips or middle/constricted sites of 
peroxisomes (n=117, positive DLP1 peroxisome structures from 5 optical sheets. 
(G-H) HeLa cells transfected with GFP-MFF, polyclonal anti-PEX14 labeled with 
a KK114-conjugated secondary (red channel, left), monoclonal anti-GFP labeled 
with Atto594 secondary (green channel, middle). Asterisks * indicate division 
sites. Arrow in (G) indicates GFP-MFF half ring structure. (I) Line scan plot of 
the line scan marked in (c). All images are raw STED or confocal data, linearly 
scaled for intensity. Scale bars 500 nm.  
 
RING and docking subcomplexes segregate on distinct adjacent 
peroxisomal membrane compartments  
Recent work in yeast showed that peroxisomes are formed by heterotypic fusion 
of PPVs carrying distinct peroxins [20]. This model implies that the RING 
subcomplex and the docking/translocation subcomplex targets to different PPVs 
before fusion. To test whether the RING and the docking complex in human cells 
target to distinct membrane vesicles or subdomains, transiently RFP- and GFP-
tagged peroxins were co-expressed in HeLa cells. As a control, the peroxisomal 
localization of the peroxins-fusions were checked by testing and confirming their 
peroxisomal colocalization with anti-catalase (Fig. 3.9). Tagged proteins were 
labeled with anti-RFP and anti-GFP nanobodies coupled to STED-compatible 
dyes. Nanobodies are tenfold smaller than conventional antibodies and therefore 
offer better localization precision of their labeled antigens in combination with 
super-resolution microscopy. PEX2 and PEX12 of the RING complex were found 
to fully overlap (Fig. 3.10A), while PEX2 did not colocalize with PEX13 structures 
(Fig. 3.10B). At the same time, PEX14 and PEX13 of the docking complex 
showed full overlap (Fig. 3.10C); however, PEX12 did not show overlap with 
PEX13 structures (Fig. 3.10D). The analysis results indicate that the docking and 






Figure 3.9 Peroxisomal localization of fluorescently labeled PEX proteins 
PEX fusion proteins transiently expressed in HeLa cells for 24 hours (left 
column). Fixed cells processed for indirect immunofluorescence using anti-CAT1 
antibody labeled by donkey anti-rabbit Cy3 secondary antibody (middle column). 









Figure 3.10 STED visualization of fluorescently tagged Docking and RING 
peroxins reveal distinct localization of each subcomplex on adjacent 
membranes.  
GFP/mCitrine and RFP fusion peroxins co-transfected in HeLa cells and fixed 24 
hours after transfection. Labeled with the GFP-ATTO647 and RFP-ATTO590 
nanobodies against GFP/mCitrine and RFP, respectively. (A) Colocalization of 
PEX2-mCitrine in (red channel, left) and TagRFP-PEX12 in (green channel, 
middle), merged overlay. (B) Line scan analysis of the line in (A). (C) 
Colocalization of PEX2-mCitrine in (red channel, left) and TagRFP-PEX13 in 
(green channel, middle), merged overlay (right). (D) Line scan analysis of the line 




PEX13 in (green channel, middle), merged overlay (right). (F) Line scan analysis 
of the line in (E). (G) EYFP-PEX12 in (red channel, left), TagRFP-PEX13 in 
(green channel, middle), merged overlay (right). (H) Line scan analysis of the line 
in (G). Line scan plot: green dashed line (green channel) and red solid line (red 
channel). Scale bar is 500nm.  
 
Super-resolution STED analysis of ZS ghosts 
The description of residual membrane structures (ghosts) in ZS cells by EM and 
indirect immunofluorescence microscopy initiated their analysis with respect to 
the cellular phenotype [43–45]. Here, STED microscopy and automated imaging 
analysis (materials and methods) were used to quantify the size and morphology 
of peroxisomal membrane ghosts in 8 ZSS patients’ HSFs (Table 3.1). In this 
study, eight different complementation groups with variable severity were 
examined by STED microscopy. Two patients with PEX1-/- mutations were 
included; a milder mutation (PEX1-G843D) with residually active PEX1 protein, 
and another with severe mutation (PEX1-I700fs) that cause early stop codon 
termination and complete loss of function [112]. An HSF cell line with healthy 
peroxisomal biogenesis served as control. Peroxisome ghosts were stained with 
anti-PMP70 and ghost clusters (particles) were identified if the thresholded 
signals (local-maxima) were localized within a Gaussian blur diameter of 100 nm 
and show minimum cluster diameters of 10 Pixels (Fig. 3.11A). Clearly distinct 
clumped ghost clusters were divided by shape parameters (CellProfiler), and the 
areas of more than 600 clusters were analyzed per condition (Fig. 3.11B). In the 
analysis, the ghost structures in ZSS patient cells reveal a significantly larger 
area compared to wild-type peroxisomes, which can reach up to 2 times the 
average size of normal peroxisome (Fig. 3.11C, Table 3.1). The increasing 
tendency in the average size of ghosts between patients seems to correlate with 
the molecular function, the severity of mutation, and the residual import activity of 
matrix proteins (Table 3.1). Eccentricity of measured structures were also 




revealed compared to ghost structures in ZSS patient cells (Fig. 3.11D). Based 
on this observation, it is possible to speculate that the de-tubulated structures of 
ghosts and their loss of membrane curvature functionally correlates with the 
impaired division of these abnormal structures [113]. 
 
Figure 3.11 ZS ghost peroxisomal remnants STED analysis.  
 (A) Super-resolution STED tiles (1000 x 1000 nm) of peroxisomal membranes 




antibodies conjugated to Atto594 dye. (B) Raw STED image of ghost clusters 
from PEX1-G843D ZS cells (1). Segmentation results of the raw image (2). 
Object map of segmented clusters (3). Gaussian filter image with diameter = 100 
nm (4). Segmentation results of Gaussian images (5). Object map of segmented 
clusters (6). (C) Gaussian analysis with Gaussian diameter of 100 nm, bar graph 
indicates mean cluster size (Total pixels) ± Std. Clusters were measured from 
(n=3) independent experiments, except for PEX6-/- (p. S232HfsX15) homozygous 
and PEX12-/+ (mosaic) (n=2). The number of ghost clusters measured per 
condition is indicated on bars and statistics relative to control peroxisome was 
calculated using two-sample t-test with significance (* P<0.01 or *** P<0.0001 
and not significant n.s). (D) Boxplot showing eccentricity calculations of the 
measured clusters. Statistics using two sample t-test for significance of the mean 
(*** P<0.0001). STED tile images in (A) were smoothened with an average 3x3 



















Table 3-1 Patients Summary 











PEX1 -/- G843D CYTO 2.0 1.07 ± 0.39 ~ 24% 
Mild  
Ref. [114, 115]   
PEX1 -/- I700FS CYTO 1.57 0.84 ± 0.25 ~ 40% 
Severe  
Ref. [116, 117] 
PEX6 -/- S232HFS CYTO 1.86 n.d. ~ 30% 
Intermediate 
Ref. [104] 
PEX13 -/- W313G CYTO 1.65 0.62 ± 0.16 ~ 66% 
Mild 
Ref. [104] 
PEX10 -/- L272FS CYTO 1.53 0.47 ± 0.06 ~ 23% Severe (this study) 
PEX2 -/- F278FS CYTO 1.42 0.39 ± 0.02 ~ 20% 
Severe  
Ref. [104]  




Mosaic 1.19 0.65 ± 0.04 ~ 72% Mild (this study) 
Control  PX 1 1 100% - 
n.d. not determined, CYTO cytoplasmic, PX peroxisomal Severe: < 1year, Intermediate: > 1 






STED resolution is essential for accurate ghost size analysis  
To address if resolution breakthrough provided by STED microscopy was 
indispensable to quantify peroxisomal ghost, a confocal-like setting was created 
by increasing the Gaussian blurring diameter to 250 nm of our STED images, the 
results changed and the overall cluster size increased, which was related to 
enlarged PSF and segmentation errors (Fig. 3.12). Therefore, STED microscopy 
and breaking the diffraction limit are essential to accurately discriminate the 
ghost structures and thereby provide accurate phenotype distribution.  
 
Figure 3.12 Diffraction-limit Gaussian blur and ghost size analysis. 
(A) Bar graph of mean ghost cluster size (in total pixels) of STED images blurred 




and *** P<0.0001). (C) Segmentation results of STED images of wild-type 
peroxisomes using 100 nm Gaussian diameter (left side) and 250 nm Gaussian 
diameter (right side). 
 
Ghost size in ZSS patients correlates with total PMP70 protein abundance     
Previously, differences in PMP70 protein abundance in liver biopsies from ZS 
patients were reported, which suggested that peroxisomal integral membrane 
proteins abundance could be critical for the ghost size [47]. To address this 
question, we carried out a quantification analysis of PMP70 in whole-cell lysates 
from homozygous ZSS patient fibroblasts of PEX1-/- (p.G843D), PEX1-/- 
(p.I700X), PEX13-/- (p.W313G), PEX10-/- (p.L272X), PEX2-/- (p.F278X), and a 
control cell line by Western blotting. PEX19-/- patient cells served as negative 
control and showed no detectable PMP70 (Fig. 3.13A). The PEX1-/-, PEX13-/-, 
and PEX12-/+ patients showed less reduction in their PMP70 levels, compared to 
homozygous patients with mutations in RING-family peroxins (Fig. 3.13B). 
Correlation analysis of ghost size and PMP70 abundance indicated a strong 





Figure 3.13 PMP70 protein level in ZS patients correlates with ghost size 
STED phenotype. 
(A) Western blot detection of anti-PMP70 from control and HFS fibroblasts. (B) 
PMP70 quantitation results (n ≥ 3 per condition). Error bar indicate standard 
deviation. (C) Pearson correlation of Ghost size and PMP70 protein expression 
relative to control. Pearson analysis significance was tested using pairwise t-
statistics (P = 0.0543). 
 
Peroxisome abundance does not correlate with PMP70 abundance  
PMP70 abundance might reflect differences in peroxisome number per cell rather 
than differences in ghost size. To analyze peroxisome ghost numbers in ZSS 




microscopy and semi-automated imaging analysis. The results of the analysis 
revealed that the numbers of peroxisomal ghosts were comparable in all ZSS 
fibroblasts, except for PEX12-/+ and PEX5-/- patients showing slightly less 
reduction in their ghost abundance (Fig. 3.14A). However, there was no 
correlation found between ghost number per cell and PMP70 abundance or 
ghost size (Fig. 3.14B).  
 
Figure 3.14 Peroxisome ghost quantification.  
(A) Bar plot show results of semi-automated analysis of peroxisome ghost. 
Number indicated on bars indicate the number of cells included in the 
quantification. Standard deviation was used to determine the error and t-statistics 
was used to test the significance (** P<0.001 and *** P<0.0001). (B) Pearson 
correlation plot of PMP70 protein abundance with peroxisome abundance (left) 
and Peroxisome abundance with ghost size (right). Pearson correlation coefficient 
(r) is indicated on each graph. 
 
 PEX2 interacts with PMP70 in vivo 
The Western blot analysis showed that PEX2-/- patient exhibited the most severe 
PMP70 abundance phenotype. Previously, our lab has shown that PEX2 
overexpression induce PMP70, which proposed a functional link between both 




mCitrine overexpression in HeLa cells (Fig 3.15A). However, in this study PEX2 
was hypothesized to be an interacting partner of PMP70 thus keeping PMP70 
stable at membranes. To test this hypothesis, an immunoprecipitation and pull 
down PEX2-mCitrine by nanobodies was performed and indeed a PEX2-PMP70 
interaction was found (Fig. 3.15B). This novel interaction may explain the 
significant reduction in PMP70 protein abundance in the PEX2-/- ZSS patient’s 
cells. To control for the function of our fusion proteins, overexpressed PEX2-
mCitrine and PEX13-mGFP (negative control) in PEX2 and PEX13 ZSS 
fibroblasts, respectively, were able to restore biogenesis as depicted by catalase 





Figure 3.15 PEX2-PMP70 interaction in vivo. 
(A) PMP70 Western blot analysis in HeLa cells with PEX2-mCitrine 
overexpression and without (control). (n = 3, one way anova, not significant n.s, 
F-ratio = 4, p = 0.157) (B) Immunoprecipitation Western blot results of PEX2-
mCitirne and PEX13-mGFP with GFP-Trap nanobody (top); co-
immunoprecipitation detection of PMP70 (bottom). (C) Control and ZS HSF cells 
transfected with EGFP-SKL or the respective PEX-Fluorescent Fusion Protein 








In this study, super-resolution STED microscopy was utilized to analyze 
peroxisome morphology and the localization of different peroxisomal proteins at 
unprecedented details. In a very recent study, STED microscopy was used to 
study the peroxisomal compartment and PEX5 distribution under overexpression 
conditions of GFP-matrix proteins in HSF cells [80]. The authors reported 
peroxisomes with an average size of ~ 350 nm, which is 2.5 times the size we 
report here (~100 nm). Earlier EM reports of wildtype peroxisomes under normal 
conditions revealed an average size of peroxisome of ~100 nm [5]. Therefore, 
the larger average peroxisomal diameter reported by Galiani et al. as compared 
to the diameter reported here indicates that overloading peroxisomes with matrix 
content has a direct effect on peroxisome size. Using STED microscopy and 
nanobodies, peroxisome diameter in yeast under glucose growth conditions was 
analyzed and yeast peroxisomes revealed a subdiffraction average diameters of 
~ 174 nm under these conditions, which is comparable to earlier EM reports (0.1 
µm – 0.2 µm)  [12]. In mammalian HeLa cells, the measured average diameter of 
hyper-tubulated peroxisome while overexpressing PEX11beta was ~ 100 nm, 
which indicated that PEX11beta does not have any effect on peroxisomal 
diameter in vivo. In contrast, recent in vitro studies carried out on proteo-
liposomes showed that PEX11beta causes membrane constrictions [33]. 
Therefore, this study provides a further quantitative evidence that PEX11beta 
only elongates and does not constrict peroxisomal membrane in vivo (Fig. 3.6E), 
in agreement with the previous qualitative EM observations [119] 
Only when peroxisomes were labeled by nanobodies and their 
subdiffraction architecture were observed by STED microscopy, it was possible 
to explain the puzzling phenotypes in yeast, associated with deletion or 
overexpression of a novel peroxisomal protein, PEX35, suggesting that PEX35 
controls peroxisome abundance via a vesicular mechanism. This has been 
supported by other functional experiments (Yofe et al, unpublished). Moreover, 




EM so far [120]. Here we show that the accurate localization of two important 
peroxisomal fission factors, DLP1 and MFF, by light microscopy, is only 
achievable with STED resolution. Altogether, this study demonstrates that 
subdiffraction fluorescence STED microscopy can be effectively used to reveal 
peroxisome morphology and proteins at a previously unseen level of detail. 
 
4.1. PEX35 a regulator of peroxisome abundance 
Peroxisome abundance is regulated by de novo formation as well as proliferation 
and division from preexisting peroxisomes. The process of peroxisome 
proliferation can be divided into three steps: 1) early membrane vesiculation, 2) 
elongation, and 3) fission [53]. Arf1 with the coatomer complex and PEX11 are 
thought to regulate early membrane vesiculation by inducing positive membrane 
curvature, which is a prerequisite for membrane elongation and polarization [121, 
122]. Once membrane curvature is induced, PEX11 functions by promoting 
membrane elongation and maintaining polarized growth of the membrane [123]. 
Recently, PEX11 has been found to activate GTP hydrolysis of DLP proteins by 
showing a selective GAP activity towards them, which suggests an additional role 
of PEX11 in peroxisome fission [124]. These data led to the hypothesis that 
PEX11 proteins orchestrate the proliferation process from the beginning to the 
end [119]; however, it remained unknown how PEX11 could regulate early 
membrane vesiculation events with Arf1 and its coatomer complex. PEX11 
expression does not affect the recruitment of Arf1 to peroxisomes [122]. Brefeldin 
A, an inhibitor of Arf1-GEF that is required for Arf1-recruitment to the Golgi, did 
not show any change in peroxisomal Arf1, which suggested that there is another 
yet unknown Arf1 receptor present on peroxisomal membranes [53]. I contributed 
to the characterization of the new peroxisomal PEX35 protein that negatively 
regulates peroxisome abundance and binds to Arf1 (Yofe et al, unpublished). 
Increased Arf1 recruitment to Golgi has been shown to increase Golgi 
vesiculation and fission [125]. This is in agreement with the STED microscopy 




peroxisomes when overexpressing PEX35, whereas pex35 deletion shows 
reduced peroxisome abundance with normal morphology. In STED microscopy, 
peroxisomes were of slightly bigger size in the knockout compared to the 
wildtype, but this difference was not statistically significant. The imaging data 
does not explain why Arf1 is depleted from Golgi membranes in both PEX35 
overexpression and deletion (Yofe et al, unpublished). One model is that PEX35 
acts as peroxisomal Arf1-GEF receptor; when PEX35 is overexpressed it 
sequesters Arf1 from the Golgi membranes, thus showing the Arf1 depletion 
phenotype from Golgi structures and leading to hyper-vesiculated peroxisomes. 
We hypothesize that when pex35 is deleted, which does not lead to peroxisomal 
hyper-vesiculation, an undescribed Arf1 dependent signaling pathway is 
delivered from peroxisomes to Golgi that leads to Arf1 dissipation and eventually 
leading to a reduction in Golgi vesiculation. It is not surprising that peroxisomes 
were found to colocalize with Golgi (Yofe et al, unpublished), and this provides 
further evidence of such a direct Arf1 dependent pathway that might exist 
between the two organelles. Another model is that PEX35 acts as a scaffold for a 
peroxisomal Arf1-GAP, or itself acts as a novel peroxisomal Arf1-GAP protein. In 
mitochondria, Arf1-GAP overexpression or Arf1-GEF deletion lead to an altered 
morphology of big and round mitochondria that was found to be clumped small 
mitochondria (mito clusters) (C.-F. Huang, Chen, Tung, Buu, & Lee, 2002), 
similar to what was observed here in peroxisomes. Deletion of pex35 (GAP) 
would then leave a peroxisomal localized Arf1-GEF active, which further 
accumulates Arf1-GTP on peroxisomal membranes that might lead to an 
inhibition rather than activation of the Arf1 mediated peroxisome proliferation. 
Similar in Golgi, glo3 deletion, a Golgi Arf1-GAP receptor, leads to reduced Golgi 
numbers per cell, slightly enlarged Golgi and reduced Arf1 puncta were also 
seen [128]. But how does this second model explain the Arf1 mislocalization from 
Golgi, in overexpression as well as deletion of PEX35? Pex35 has been shown 
to interact with Sec7, a Golgi Arf1-GEF. When PEX35 is overexpressed, Sec7 is 
sequestered from the Golgi membrane and therefore Arf1-GTP accumulation at 




peroxisomal Arf1-GEF leads to the sequestration of the Arf1 active pool, and 
competes with the Arf1 cycle at the Golgi leading to reduced Arf1 puncta, which 
represent the majority of Golgi membranes. 
 Current findings suggest Arf1 to be a key factor in balancing cross-talk 
between peroxisomes and the Golgi. Organelle-coupling does not seem to be a 
new role of Arf1, as it has been shown to regulate mitochondrial morphology and 
ER-mitochondrial communication [126]. In the future, the contact-sites and 
communication between Golgi and peroxisomes will be an interesting field to 
study in detail. It will improve our understanding of the relationship between 
peroxisomes and the secretory pathway, in which the Golgi plays a central role. 
Ultimately, this will improve our understanding of how a cell drives its 
homeostasis and efficiently couples its metabolic and secretory activities and 
what goes wrong in various pathologies. 
 
4.2. Mammalian peroxisomal translocon proteins 
localizations 
The process of biogenesis of peroxisomes has been extensively studied, but still 
fundamental aspects are highly debated and remain to be elucidated. De novo 
formation of peroxisomes has revealed an important role of the endoplasmic 
reticulum in this process [129–131]. Co-localization microscopy and split-protein 
assays in yeast have shown RING and docking factors, subcomplexes of the 
peroxisome translocon, to localize to distinct membrane substructures or vesicles 
in pex6 and pex1 mutant strains, which are referred to as pre-peroxisomal 
vesicles (PPVs) that derive from ER [20]. Other recent studies did not find 
differences in the distributions of docking and RING peroxins, even in pex1 and 
pex6 mutants, their results might have been limited by the resolution restrains of 
widefield colocalization microscopy [22]. Surprisingly, in mammalian cells the 
colocalization of the RING factors and docking factors has not been investigated. 




labels, and STED microscopy were used to study the colocalization of RING and 
docking peroxins in mammalian cells. Our data revealed peroxisomal 
substructures enriched with RING peroxins distinct from those enriched by 
docking peroxins. Future studies using efficient super-resolution microscopy 
labels directed against native docking and RING peroxins, will help us to 
understand the structural and functional arrangement of the peroxisomal factors 
making up the translocon at greater details. However, our results raise questions 
about the function of these highly enriched and distinct peroxisomal 
substructures and their involvement in peroxisome translocon biogenesis and 
import. 
 
4.3. ZSS ghost phenotype characterization 
The description of residual membrane structures (‘ghosts’) in ZSS patient cells by 
EM and indirect immunofluorescence microscopy has been important for 
connecting the genetic defect with the cellular phenotype [44]. We used STED 
microscopy to further characterize and quantify the morphology the peroxisomal 
ghost structures in ZSS patients with different PEX mutations. We have found 
that AAA and docking peroxin mutations show larger average peroxisomal ghost 
sizes, whereas RING-family peroxins mutations revealed compact and smaller 
peroxisomal ghosts. Residual matrix content has been shown in AAA peroxins 
and PEX13 deletions [103, 132, 133]; we therefore hypothesize that the ghost 
phenotype correlates with residual import. This is in agreement with the different 
phenotype observed in our two PEX1-/- patients, with most severely affected 
protein (p.I700fsX42) showing smaller peroxisomal ghost size compared to the 
one with least severe mutation (p.G843D). The PEX1 G843D-/- allele has been 
shown to have residually active PEX1 protein function, which leads to active 
residual import of matrix proteins compared to the more severe allele I700fs-/- 
with no active PEX1 protein function and thus hardly any residual import activity 




RING factors have abolished peroxisomal import of PTS1 and/or PTS2 targeted 
proteins [134, 135, 136].  
Another factor that might cause variations in the ghost size is differences 
in the abundance of integral PMPs. Earlier, differences in PMP protein 
abundance has been observed in various ZSS patients’ liver biopsies [44, 136]. 
Here, we show a positive relationship between PMP70 and ghost size 
phenotype. Why would less PMP70 lead to smaller ghost size? It is reasonable 
to think that differences in PMP70 protein abundance could be a result of 
translocon assembly defects, where some peroxin mutations might interfere with 
the overall integrity of PMPs at peroxisomal membranes. This is supported by the 
severely reduced PMP70 abundance in the PEX2-/- patient and the identification 
of a PEX2-PMP70 interaction. At the same time, integral PMPs might have a 
direct effect on peroxisomal membrane formation. To prove this, depletion of 
various integral PMPs in fission defect peroxisomes should show a similar 
phenotype correlation between peroxisome size and PMP abundance. 
Experiments on different organelles have revealed similar effects of reduced 
membrane protein abundance on organelle size and membrane ultrastructure 
[137, 138]. Finally, variabilities in the ZSS ghost’s phenotype may be a 
combination of residual import activity, local PMP stability, and further unknown 
factors that associate with the pathological state of ZSS disorders. In the future, 
to accurately identify the protein content of peroxisomal ghost vesicles and their 
respective size we would have to measure the copy number of ghosts, the 
amount of associated proteins and the size of ghosts simultaneously on a single 
molecule and a single vesicle basis, which could be achieved by peroxisome 
vesicle separation and proteomics on purified peroxisomal ghosts. 
   
In conclusion, STED resolution is critically required for accurate 
characterization and quantification of the ghost morphology in ZSS patient cells 
since emulating confocal images from the STED images by Gaussian blurring 




confocal resolution. This work further shows that not only residual import function 
correlates with the prognosis of ZSS patients, but also a sub-diffraction 
morphological ghost phenotype. In future, the sub-diffraction morphological 
analysis of the ghost phenotype of ZSS patients could be implemented in the 
clinical practice and complement other prognostic and diagnostic tests for 
peroxisomal disorders. This will lead to a better understanding of the molecular 
pathology of ZSS and path the way to establish therapeutic approaches.   
5. Conclusion 
The work described here shows how super-resolution microscopy can be used in 
addition to other techniques to reveal new information about peroxisomal 
proteins and the morphology of peroxisomes in yeast and human cells. Clinically 
significant, we have found that the cellular peroxisomal ghost phenotype in the 
cells of ZSS patients correlates with the molecular and clinical severity of the 
disease. Finally, the experiments and analysis presented in this thesis provide a 
starting point for future studies on the application of super-resolution microscopy 
















6.1. Matlab Script codes 
%% Calculate diameter of peroxisome automatically from all selected CSV reads 
[Filename,PathName]=uigetfile({'*.csv*'},... 
  'Multiselect', 'on'); 
   cd(PathName); 
   for k = 1:length(Filename) 
       file = fullfile(PathName, Filename{k}); 
 fid= fopen(file, 'r'); 
 fgets(fid);  
if isequal(fid,0) 
   disp('User selected Cancel') 
else 
readData = textscan(fid,'%f %f','HeaderLines',1,'Delimiter',','); 
xData = readData{1,1}(:,1); 
yData = readData{1,2}(:,1); 
f1 = fit(xData*1000,yData,'gauss2') 
coeffvalues(f1) 
a = ans(:,2) 
b = ans(:,5) 
diameter(k) = a-b 






   end 
    B = transpose(diameter_positive) 
  csvwrite('diameter_results.csv',B); 
 %% Calculate FWHM automatically from all selected CSV reads 
[Filename,PathName]=uigetfile({'*.csv*'},... 
  'Multiselect', 'on'); 
   cd(PathName); 
   for k = 1:length(Filename) 
       file = fullfile(PathName, Filename{k}); 
 fid= fopen(file, 'r'); 
 fgets(fid);  
if isequal(fid,0) 
   disp('User selected Cancel') 
else 
readData = textscan(fid,'%f %f','HeaderLines',1,'Delimiter',','); 
xData = readData{1,1}(:,1); 
yData = readData{1,2}(:,1); 
f1 = fit(xData*1000,yData,'gauss1')  
coeffvalues(f1) 
a = ans(:,3) 
FWMH(k) = a 






   end 
    B = transpose(FWMH_positive) 
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